NZ618123B2 - Algal lipid compositions and methods of preparing and utilizing the same - Google Patents
Algal lipid compositions and methods of preparing and utilizing the same Download PDFInfo
- Publication number
- NZ618123B2 NZ618123B2 NZ618123A NZ61812312A NZ618123B2 NZ 618123 B2 NZ618123 B2 NZ 618123B2 NZ 618123 A NZ618123 A NZ 618123A NZ 61812312 A NZ61812312 A NZ 61812312A NZ 618123 B2 NZ618123 B2 NZ 618123B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- algae
- source
- culture medium
- algal
- culture
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title description 99
- 239000000203 mixture Substances 0.000 title description 93
- 239000002028 Biomass Substances 0.000 claims abstract description 210
- 241000195493 Cryptophyta Species 0.000 claims abstract description 153
- 238000000034 method Methods 0.000 claims abstract description 77
- 239000001963 growth media Substances 0.000 claims abstract description 70
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 54
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 54
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229940041514 Candida albicans extract Drugs 0.000 claims abstract description 37
- 239000012138 yeast extract Substances 0.000 claims abstract description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 26
- 239000011780 sodium chloride Substances 0.000 claims abstract description 26
- 239000010452 phosphate Substances 0.000 claims abstract description 22
- 239000011777 magnesium Substances 0.000 claims abstract description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 20
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 19
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 18
- 239000011575 calcium Substances 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 13
- 239000002609 media Substances 0.000 claims description 75
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 45
- 235000000346 sugar Nutrition 0.000 claims description 40
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 34
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 34
- 150000002500 ions Chemical class 0.000 claims description 33
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 29
- 239000008103 glucose Substances 0.000 claims description 29
- 238000003306 harvesting Methods 0.000 claims description 27
- 235000002639 sodium chloride Nutrition 0.000 claims description 24
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 23
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 23
- 239000004202 carbamide Substances 0.000 claims description 17
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 15
- 239000001110 calcium chloride Substances 0.000 claims description 15
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 15
- 235000015097 nutrients Nutrition 0.000 claims description 14
- 239000001301 oxygen Substances 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 11
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 8
- GNSKLFRGEWLPPA-UHFFFAOYSA-M Monopotassium phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 7
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 7
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 7
- 238000010923 batch production Methods 0.000 claims description 5
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 3
- 241000003595 Aurantiochytrium limacinum Species 0.000 claims 1
- 239000003925 fat Substances 0.000 description 91
- 235000019197 fats Nutrition 0.000 description 91
- 210000004027 cells Anatomy 0.000 description 49
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 48
- 235000014113 dietary fatty acids Nutrition 0.000 description 48
- 239000000194 fatty acid Substances 0.000 description 48
- 150000004665 fatty acids Chemical class 0.000 description 48
- 239000002253 acid Substances 0.000 description 40
- 210000002414 Leg Anatomy 0.000 description 36
- 239000003921 oil Substances 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 29
- 210000002421 Cell Wall Anatomy 0.000 description 28
- 235000013305 food Nutrition 0.000 description 28
- 230000012010 growth Effects 0.000 description 27
- 229960001031 Glucose Drugs 0.000 description 26
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 239000000126 substance Substances 0.000 description 24
- 239000000306 component Substances 0.000 description 23
- 239000003795 chemical substances by application Substances 0.000 description 22
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 22
- 229940091258 Selenium supplements Drugs 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 229910052711 selenium Inorganic materials 0.000 description 21
- 239000011669 selenium Substances 0.000 description 21
- 239000000284 extract Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 20
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 19
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 201000010099 disease Diseases 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 235000013601 eggs Nutrition 0.000 description 14
- 239000000446 fuel Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 235000015872 dietary supplement Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 230000002829 reduced Effects 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 150000003626 triacylglycerols Chemical class 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 11
- 230000003698 anagen phase Effects 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 238000000605 extraction Methods 0.000 description 10
- 230000035492 administration Effects 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- -1 tissues Substances 0.000 description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 8
- 239000003674 animal food additive Substances 0.000 description 8
- 230000001965 increased Effects 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 8
- 244000202285 Acrocomia mexicana Species 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 239000007921 spray Substances 0.000 description 7
- 210000001519 tissues Anatomy 0.000 description 7
- 235000003625 Acrocomia mexicana Nutrition 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 238000007667 floating Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000002335 preservative Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 230000001225 therapeutic Effects 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 241000209149 Zea Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 230000001133 acceleration Effects 0.000 description 5
- 239000011260 aqueous acid Substances 0.000 description 5
- 239000002551 biofuel Substances 0.000 description 5
- 230000001413 cellular Effects 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 235000005824 corn Nutrition 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 235000013379 molasses Nutrition 0.000 description 5
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 150000003342 selenium Chemical class 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229930003231 vitamins Natural products 0.000 description 5
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 4
- 230000005526 G1 to G0 transition Effects 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 4
- 229960002718 Selenomethionine Drugs 0.000 description 4
- 229940035295 Ting Drugs 0.000 description 4
- 229940029983 VITAMINS Drugs 0.000 description 4
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000019728 animal nutrition Nutrition 0.000 description 4
- 125000004429 atoms Chemical group 0.000 description 4
- 238000004061 bleaching Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 4
- 239000010685 fatty oil Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 230000000670 limiting Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 230000001264 neutralization Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 210000004379 Membranes Anatomy 0.000 description 3
- 229940067631 Phospholipids Drugs 0.000 description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L Sodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 239000003225 biodiesel Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000001627 detrimental Effects 0.000 description 3
- 235000007882 dietary composition Nutrition 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005189 flocculation Methods 0.000 description 3
- 230000016615 flocculation Effects 0.000 description 3
- 230000002068 genetic Effects 0.000 description 3
- 230000000102 heterotrophic Effects 0.000 description 3
- 239000008079 hexane Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003834 intracellular Effects 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000011781 sodium selenite Substances 0.000 description 3
- 229960001471 sodium selenite Drugs 0.000 description 3
- 235000015921 sodium selenite Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229940077731 Carbohydrate nutrients Drugs 0.000 description 2
- 208000008787 Cardiovascular Disease Diseases 0.000 description 2
- 210000000170 Cell Membrane Anatomy 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 229960002737 Fructose Drugs 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 2
- 229960002160 Maltose Drugs 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N N-(2-chloroethyl)-N-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229940116542 OTHER NUTRIENTS in ATC Drugs 0.000 description 2
- 229940012843 Omega-3 Fatty Acids Drugs 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 229960004793 Sucrose Drugs 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SQOUGZDYSA-N Xylose Natural products O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L Zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000000996 additive Effects 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- DTYCRHCCLVCUDT-UHFFFAOYSA-J calcium;magnesium;tetrachloride Chemical compound [Mg+2].[Cl-].[Cl-].[Cl-].[Cl-].[Ca+2] DTYCRHCCLVCUDT-UHFFFAOYSA-J 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000034303 cell budding Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- ATORBMMJNYFMAK-UHFFFAOYSA-L cobalt(2+);selenate Chemical compound [Co+2].[O-][Se]([O-])(=O)=O ATORBMMJNYFMAK-UHFFFAOYSA-L 0.000 description 2
- HNZYCXDYRNOVLJ-UHFFFAOYSA-L cobalt(2+);selenite Chemical compound [Co+2].[O-][Se]([O-])=O HNZYCXDYRNOVLJ-UHFFFAOYSA-L 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000002939 deleterious Effects 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 230000000378 dietary Effects 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000003502 gasoline Substances 0.000 description 2
- 235000003869 genetically modified organisms (GMOs) Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 200000000018 inflammatory disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000002427 irreversible Effects 0.000 description 2
- 239000003350 kerosene Substances 0.000 description 2
- 238000011031 large scale production Methods 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 210000001699 lower leg Anatomy 0.000 description 2
- 230000002934 lysing Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- 235000015074 other food component Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000002441 reversible Effects 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 238000004642 transportation engineering Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- HPSWUFMMLKGKDS-DNKOKRCQSA-N (2E,4E,6E,8E,10E,12E)-tetracosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O HPSWUFMMLKGKDS-DNKOKRCQSA-N 0.000 description 1
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 1
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 1
- ARSRBNBHOADGJU-UHFFFAOYSA-N 7,12-dimethyltetraphene Chemical compound C1=CC2=CC=CC=C2C2=C1C(C)=C(C=CC=C1)C1=C2C ARSRBNBHOADGJU-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 241001261858 Alsodes Species 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 235000009825 Annona senegalensis Nutrition 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N Anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003246 Arthritis Diseases 0.000 description 1
- 241000209134 Arundinaria Species 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 101710011225 BHLH76 Proteins 0.000 description 1
- 241000219430 Betula pendula Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N Chlormethine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 208000004981 Coronary Disease Diseases 0.000 description 1
- 206010011401 Crohn's disease Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 210000000805 Cytoplasm Anatomy 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N Ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 229940093500 Ethoxyquin Drugs 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 210000002816 Gills Anatomy 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N Guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 241001303069 Hemiselmis Species 0.000 description 1
- 101700001236 INTU Proteins 0.000 description 1
- 206010021972 Inflammatory bowel disease Diseases 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L Iron(II) sulfate Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K Iron(III) chloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 101700036384 LAG2 Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000283953 Lagomorpha Species 0.000 description 1
- 210000004072 Lung Anatomy 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229940045184 Malt extract Drugs 0.000 description 1
- LUEWUZLMQUOBSB-GFVSVBBRSA-N Mannan Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229960004961 Mechlorethamine Drugs 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000000214 Mouth Anatomy 0.000 description 1
- 210000002200 Mouth Mucosa Anatomy 0.000 description 1
- 206010028520 Mycotoxicosis Diseases 0.000 description 1
- 231100000006 Mycotoxicosis Toxicity 0.000 description 1
- 208000010125 Myocardial Infarction Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- JZWFDVDETGFGFC-UHFFFAOYSA-N N-acetyl-2-hydroxybenzamide Chemical compound CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 241000343232 Oia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000690470 Plantago princeps Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 206010037175 Psychiatric disease Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 101710025953 SPBP8B7.29 Proteins 0.000 description 1
- 101700050571 SUOX Proteins 0.000 description 1
- 241000233671 Schizochytrium Species 0.000 description 1
- QYHFIVBSNOWOCQ-UHFFFAOYSA-N Selenic acid Chemical compound O[Se](O)(=O)=O QYHFIVBSNOWOCQ-UHFFFAOYSA-N 0.000 description 1
- 229940000207 Selenious Acid Drugs 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N Selenium Sulfide Chemical class [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- LIRMPIXWGWLNND-UHFFFAOYSA-N Selenium oxydichloride Chemical compound Cl[Se](Cl)=O LIRMPIXWGWLNND-UHFFFAOYSA-N 0.000 description 1
- LNBXMNQCXXEHFT-UHFFFAOYSA-N Selenium tetrachloride Chemical compound Cl[Se](Cl)(Cl)Cl LNBXMNQCXXEHFT-UHFFFAOYSA-N 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-N Selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
- 241001036256 Senobasis corsair Species 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- 240000003670 Sesamum indicum Species 0.000 description 1
- 229940073490 Sodium Glutamate Drugs 0.000 description 1
- MHQOTKLEMKRJIR-UHFFFAOYSA-L Sodium selenate Chemical compound [Na+].[Na+].[O-][Se]([O-])(=O)=O MHQOTKLEMKRJIR-UHFFFAOYSA-L 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- JIWBIWFOSCKQMA-LTKCOYKYSA-N Stearidonic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O JIWBIWFOSCKQMA-LTKCOYKYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 240000008529 Triticum aestivum Species 0.000 description 1
- 229960004528 Vincristine Drugs 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 229960003487 Xylose Drugs 0.000 description 1
- 229940091251 Zinc Supplements Drugs 0.000 description 1
- DZHMRSPXDUUJER-UHFFFAOYSA-N [amino(hydroxy)methylidene]azanium;dihydrogen phosphate Chemical compound NC(N)=O.OP(O)(O)=O DZHMRSPXDUUJER-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001058 adult Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 102000004965 antibodies Human genes 0.000 description 1
- 108090001123 antibodies Proteins 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007172 antigens Proteins 0.000 description 1
- 102000038129 antigens Human genes 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000001320 atherosclerosis Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001651 autotrophic Effects 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- MNBLRJWKVLRTKV-UHFFFAOYSA-N bromo selenohypobromite Chemical compound Br[Se]Br MNBLRJWKVLRTKV-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000000271 cardiovascular Effects 0.000 description 1
- 238000004517 catalytic hydrocracking Methods 0.000 description 1
- 210000003850 cellular structures Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052803 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 235000019516 cod Nutrition 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 201000008739 coronary artery disease Diseases 0.000 description 1
- 230000000593 degrading Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000249 desinfective Effects 0.000 description 1
- 230000001809 detectable Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 108060002971 flz Proteins 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- IQLUYYHUNSSHIY-UHFFFAOYSA-N icosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCC=CC=CC=CC=CC(O)=O IQLUYYHUNSSHIY-UHFFFAOYSA-N 0.000 description 1
- BBWMTEYXFFWPIF-UHFFFAOYSA-N icosa-2,4,6-trienoic acid Chemical compound CCCCCCCCCCCCCC=CC=CC=CC(O)=O BBWMTEYXFFWPIF-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 230000001524 infective Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000000366 juvenile Effects 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 230000001665 lethal Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 229960003390 magnesium sulfate Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-UHFFFAOYSA-M monosodium glutamate Chemical compound [Na+].[O-]C(=O)C(N)CCC(O)=O LPUQAYUQRXPFSQ-UHFFFAOYSA-M 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative Effects 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 101700047848 pabA Proteins 0.000 description 1
- 101700043868 pabB Proteins 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 230000000135 prohibitive Effects 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 201000004681 psoriasis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002285 radioactive Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000000979 retarding Effects 0.000 description 1
- 230000002207 retinal Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000000630 rising Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 229950009280 salacetamide Drugs 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 150000003343 selenium compounds Chemical class 0.000 description 1
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Chemical compound [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- AWLUSOLTCFEHNE-UHFFFAOYSA-N sodium;urea Chemical compound [Na].NC(N)=O AWLUSOLTCFEHNE-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KKEOZWYTZSNYLJ-UHFFFAOYSA-O triazanium;nitrate;sulfate Chemical compound [NH4+].[NH4+].[NH4+].[O-][N+]([O-])=O.[O-]S([O-])(=O)=O KKEOZWYTZSNYLJ-UHFFFAOYSA-O 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009875 water degumming Methods 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 235000021307 wheat Nutrition 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/02—Liquid carbonaceous fuels essentially based on components consisting of carbon, hydrogen, and oxygen only
- C10L1/026—Liquid carbonaceous fuels essentially based on components consisting of carbon, hydrogen, and oxygen only for compression ignition
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L2200/00—Components of fuel compositions
- C10L2200/04—Organic compounds
- C10L2200/0461—Fractions defined by their origin
- C10L2200/0469—Renewables or materials of biological origin
- C10L2200/0476—Biodiesel, i.e. defined lower alkyl esters of fatty acids first generation biodiesel
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L2200/00—Components of fuel compositions
- C10L2200/04—Organic compounds
- C10L2200/0461—Fractions defined by their origin
- C10L2200/0469—Renewables or materials of biological origin
- C10L2200/0484—Vegetable or animal oils
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Abstract
process of making an algal biomass comprising at least 67% total fat comprises culturing an algae in two or more types of culture medium sequentially, culturing the algae in a culture medium comprising a carbon source, yeast extract, a magnesium source, and a calcium source; and subsequently, culturing the algae in a culture medium comprising a carbon source, a yeast extract, a nitrogen source, a phosphate source, a magnesium source, a calcium source, and 4 g/L or less of sodium chloride where the nitrogen and phosphate are in a ratio of 50:1 to 4:1. uring the algae in a culture medium comprising a carbon source, a yeast extract, a nitrogen source, a phosphate source, a magnesium source, a calcium source, and 4 g/L or less of sodium chloride where the nitrogen and phosphate are in a ratio of 50:1 to 4:1.
Description
PCT/U82012/046696
ALGAE. LIPID COMPOSITIONS AN!) METHODS OF PREPARENG AND
UTILIZING THE SAME
This Application claims priority to US Provisional Patent Application Serial No.
:3 (ii/507,390 filed 13 July 201 it, hereby incorporated hy reference in its entirety.
FIELD OF THE ENVENTEON
This invention relates to compositions comprising high lipid content algae and
methods of making and utilizing the same. ln particular, the invention relates to high lipid
it) content algae biomass and algal lipid materials d from the same. methods ofnialiing
the same, as well as to hiolitels (ea, hiodiesel) and dietary compositions (e.g., animal feeds)
sing or made from the same. Compositions and methods of the invention lind use in a
variety of anplieations including biofuel, dietary (ego, human and animal nutrition):
therapeutic as well as research applications.
BACKGROEIND (FF THE INVENTION
Within the last several years, the production ofhiohiel (e. 0’0 from algae has
.6 hiodiesel)
been an area of interest. in part, this is due to high quality agricum tttral land not being
ed to grow algae (algal biomass). However, commercial production of bioluel t e.g,
hiodiesel) from algae has remained a nge.
in addition over the last fifty years, approaches toward providing animal nutrition
have changed. No longer are animals fed whatever forage or other material that may be
available. instead, the diets of s are closely red for total nutrition value and
cost. Very often. animals on ic diets are red for quality and performance
characteristics with the mttritional components of the feed being adiusted to maximize
nutrition value or” the feed and optimization of animal performance characteristics.
However, cost is a critical factor. There is a continual search for ffective animal
feedsg not only to sustain animalsq hut in many cases to cause enhanced growth and value.
LA! we
SUMMARY OF THE lNVENTlQN
The it vention relates to compositions sing high lipid content algae and
methods ofmalring and utilizing the same. in particular, the invention relates to high lipid
PCT/U82012/046696
content algae biomass and algal lipid materials derived from the same, methods ot‘making
the same, as well as to biolircls (eg, biodiesei) and dietary compositions (cg, animal feeds)
conmrisiug or made from the same, Compositions and methods ot‘tlie invention find use in a
variety of ations including biofuel, y leg, human and animal nutrition),
U1 therapeutic as well as research applications.
Accordingly, the invention provides a s of ng an algal biomass comprising
a desired, high fat content tog, at least 67% total fat) comprising culturing an algae under
culture conditions sufficient to provide an algal biomass comprising a desired, high fat
content. The ion has identified culture ions under which it is possible to obtain
l 0 an algal biomass comprising a desired level of total fat (eg, at least 6796 total fat). The
invention is not limited to the total fat content (eta, by weight) of an algal biomass generated
according to the invention. in a preferred embodiment, an algal s generated and/or
used aceording to the invention comprisesa tat content of at least 679/6er weight. However
themyention also des compositions and methods of generating an algal biomass
containing greater {ega ,f5reater than 689-6 r than 69%, r than 70%, greater than
7196o, greater than 7296, greater than 739’A), greater than ‘4796, greater than 7596, greater than
76%, greater than 7/9”A), greater than 7896, greater than 7996, greater than 8096, r than
8l96a, greater than 8296.greater than 85%,, or more) or lesser (eg, about 6696, about 659/o,
about 6496, about 63%, about 6296, about , about 6096, about 5996, about 5896, about
5796, about 5696about 559.6, about 549/0, or loss) amount ottotal tat lodeed, methods and
compositions described herein can be utilized to generate an algal biomass containing any
desired level ottotal fat content. in some embodiments, the algae biomass is cultured in two
or more types of culture medium in a sequential manner. For example, in some
embodiments, one culture medium of the two or more culture medium contains 50 g/L of a
L! carbon source, about 75 g/L yeast extract, about 0‘ l5 g/L magnesium sulfate, about Ojlfr g/L
calcium chloride and lllfi g/L magnesium chloride. The invention is not limited by the
carbon source indeed a variety oi carbon sources may be usedincluding, but not limited to,
carbohydrates such as glucose, fructose, , saccharose, maltose or soluble. starch as well
as oleic acid, tats such as soybean oil, molasses, glycerol, ‘1nannitol. and sodium acetate,
(,2 cotton seed llour, ol, molasses and corn steep liquor. in some embodiments, another
e medium ott‘i.to two or more culture medium contains 50g/L of a carbon source about
7.5 sol ye:ast ex tract, about 4.0 g/L magnesium sulfate, about l g/L urea, about 2 g/L m
chloride, about 2 g/L magnesium chloride and about (i25 g/L monopotassiun’r phosphate. in
some embodiments, one culture medium ofthe two or more culture medium contains a
PCT/U82012/046696
carbon source, yeast extract and sea salt. in some embodiments, and as described ,
algae are cultured a first e medium leg, ccntaining glucose, yeast t and sea
salt); erred into and incubated in a second culture medium leg.y containing glucose,
yeast extract. magnesium sulfate, calcium chloride and magnesium cl’tloride); and transferred
U1 intu and incubated in a third culture medium (ring, cunlainlng glucose, yeast extract,
magnesium sulfate” urea, calcium chloride, magnesium chloride and monopotassium
phosphate). ln some embodiments, one ofthe e mediums is supplemented with a. fed—
batch feed. in a preferred embodimenn the third culture medium is supplemented with a led—
batch feed. The invention is not limited by the type, or duration,” oiled-batch feed utilized.
l 0 in some embodimentsfi the fed-batch feed comprises urea and monopotassium phosphate.
The invention is not limited by the amounts and/er ratios of media components used in the
cultures. Examples that may be utilized as components of each of the various media leg,
first culture media, secnnd e media. batch media and ted-batch media) are described in
detail herein, ln some embodiments. the algal biomass is harvested from a e leg, from
a third cultur medium) between 12—24 hours after ion of the fed-batch process. in
some ments, the algal biomass is harvested from the third culture medium after all cf
the nutrients have been removed/consumed from the medium. The invention is not limited
by the way in wl oh the algal s is harvested. indeed, a variety of ways may be used to
t the biomass including, but not limited to, the methods described herein. in some
embodiments, the algal blurnass is harvested via ccntritirgation. in some ments, the
culture medium comprising the algal biomass is chilled prior to harvesting the algal biomass.
The invention is not limited by the temperature to which the culture n'lcdium sing the
algal biomass is chilled prior to ting. indeed, a variety of temperatures may be used
including but not limited to, those described . in some embodiments? the culture
L! medium comprising the algal biomass is chilled to between about 5. and 35 C. The invention
is net limited by the type of algae used in the invention , a variety ofalgae may be
used (eg. independently or in combination) including, but not limited to, these described
herein. in some embodimentsj the algae is a strain or species from the genus (.hlor'ellu, the
genus Schifzadzytr'itmz, or the genus Cryptizecodinimn. in a preferred embodiment, the algae
(,2 is Schizochyzrium u.“imacirtum. in some embodiments the first culture medium contains about
50 g/L glucose. about it) g/L yeast extract and about cl— g/L sea salt. in some embodiments
the second culture medium contains about 50. g/l. glucose. about 75 gill. yeast extract, about
(l.l5 g/L magnesium sulfate, about (1.15 g/l calcium chloride and (llS g/L magnesium
chluride. in some embodiments, the third culture medium cunt‘ains about 50 g/L glueoset
PCT/U82012/046696
about 7.MgL Least extract, about 4.0 g/L magnesium e, about i g/L urea, about 2 g’L
calcium chloride, about 2 g/L magnesium chloride and about 0.25. g/L monopotassium
phosphate. in some embodiments, the culture conditions comprise running the algae cu ltur3.
at 30 C under airflow and agitation conditions so as to maintain dissolved oxygen at about
U1 lilo/LL. in some embodiments, the third e meriiurn’< e.g, the culture media present at the
time olmoL[21tion oi a main tor Leg... 7'13 ,.t)l)l3 L. ill)000 L 256,000 L vessel»
contains medium with an initial ratio of nitrogen {N}:phosphoms (Pfipotassium (K) of
46: l3:8.5. In a red embodiment, the N3P1K ratio is the same in the batch and fed~l3atoh
cuiiure modes. in some embodiments, the ratio of magnesiumMg):calcium (Cat)is 3: lin
1 0 culture media usedin both batch and LlL nroo3s, at LlLoL gh higher . 4:1 to: l, or
more) and lower (eg, 2.5:1, 2:1. 1.521, or lower) ratios may he used. in another
embodiment, the ratio of chloride (CTlEjlzsullate ($04)} of l:i is used in culture media used in
both batch and tied-hatch modes, although higher (eg, 2:], 3:l, 4: 1, 5: L or more) and lowe
(eg, l:?., 1:3. 1:4, L5“, or lower) ratios may be used. In some embodiments, the ratio of
e (804:3:phosohate (P04) in media at the time of inoculation ofa rnain l‘er’rnentor (eg.
70,(300 L, ii) L,L256LOOG L vessel)(“\V is: 16:1, although higher (cg, 20:1, 25:1, 30:1, 32:1,
or more) and lower {3.0
.L., lt):l, 8:1.5.:l.3:,l or low3r}, ratios new be us3Ll.
in some
embodiments, the total ratio of sulfate (SO4):phosphate (PO4) that has been batched and fed
at the end of a iull culture (e0L iist seed stage, second seed stage and
L including inoculun‘LLt
main fortnetnor out turn.s) that ganrath an algal hiLLant soofltainiug a d fat content
(cg, greater than 67% fat; is5 although higher Log, 5. 5:,1 57: l 6: l 7: 1 8:1 or higher)
anr‘lluwoi (cc.2., 51, 4.5.,1 4: i 5: l, or 1cowr) ratiosmay he use(l. in some embodiments, the
ratio of chloride ((312)):phosphate (P04) in media at the time ofinooulation of a main
fermentor (e.g., 70,000 L, lZO, ll0C3 l- 256,GOGL.VL.essl)is L o laithough
, higher Leg, ‘20:},
L! 25:1, 302i, 32:1, or more) and lower Leg, l0: l, 8zl. 5:1, 3th or lower) ratios may he used.
in some embodiments, the total ratio of chiioritie (€32) :phL hate (3’04) that has been hatched
and fed at the end or a hill culture to.g, including inoculurn, first seed stage. second seed
stage and main ferntentor cultures) that generates an algal biomass containing a desired fat
contentLog.,greater than ()7A) fat) is 5.3:1, although higher Leg. 5.5:l, 5.7:1. 6:1, 7zl, 8zl or
(,2 higher) and lower Leg, 5:1, 45:21, 4:1. 3:i, or lower) ratios may he used.
The invention also provides an algal biomass having a desired, high fat content Leg.
total fat cont-Lnt of at least 67% by weight). in some embodiments, the biomass comprises
about 17ll~250 nit/"g Liocosahexaenoio acid (DHA) and/or about l5 (1400 trig/g palnntie acid
in some embodiments, the ion provides a lipid oornposition. a food product or other
PCT/U82012/046696
al comprising the algal biomass (eg, {tried algal biomass) or a component f
(eg, a fatty acid component thereof} in some etnbociiments, the aigai biomass tag, a dried
aigai biomass (gig, generated according to a method described herein» contains a desired
amount of total fat and/or other components tag. gteatei than about 689/1, total fat, greater
U1 than about 69% total fat, greater than about 70% totai fat, greater than about 7l9/t'1 total fat,
greater than about/2941 total fat greater than about 739/21 total fat greater than about 7.49/13totai
fat, greater than about 75% total fit, greater than about 76% total fat, r than about 77%
total fat, or greater than about 7894:; total fat). In some enib )tii'ments, an aigal biomass of the
inventiont:‘g, containing ”reater 9/E1 total tar3 is tlried such that the s contains
l 0 less than 5% moisture (eg less than 4.5% moisture, iess thaii=1% moisture, iess than 315%
moisture, less than2% moisture, less than9 5.9/0, moisture, less than 2% moisture or tess than
1.5% moisture). in some embodiments, an algal biomass of the invention (eg, a {tried
biomass containing less than 5% moisture) contains about ”ti-250 ing/g or more
tineosahexaenoic acid (DHA) (eg, about Wit—180 ing/g DEA, about 180—190 trig/g DHA,
about 190200 trig/g DH/‘t, about 200thi trig/g DHA, about 210220 trig/g DHA, about 220-
230 trig/g/-o DEA, about 230-240 trig/g Di—LA about 249-250 nag/g Di—iA, or more than 250
trig/g DHA) insome embodiments, an aigai hiontass of the invention (eg, a dried biomass
containing less than 5% moisture) ns about l50—400 or more paintitic acid
(lUPAC nanie: hexadettanoio acid (e.g, about ) trig/L9: about 200225 trig/g about
225-250 trig/g, about 250-275 nag/g, ahont 275-3130 nigxp, about 306-325 inc/g about 375-
350 tog/g, about 3503175 nag/g, about 375—400 trig/g, or more than 400 ing.«’g)), l n some
embodiments, an aigai biomass of the invention (cg, a dried biomass containing less than
'9/13 moisture) contains about 300-600 nig/g or more totai fatty acids (eg, about EGG-350
ing/g? about 0 nag/g, about 400—450 nig/g, about 450600 nag/g, about 500-559 trig/g,
L! about 550-691) 1“fig/e or more than 600. mg; 2" fatty acidsi) in some embodiments an algal
biomass of the invention tag, a dried biomass containing less than 5943 moisture) contains
less than ahonti{5% n (e.a, less than about l)0 protein, toss than about 13'721 protein,
less than about 12% protein, less than about t 1% protein, less than about M21941 n, less
than about 990 protein, or less than about 8% protein), ln some embodiments, an algal
(,2 biomass or component tltereot‘of the invention is used in preparing biofnei (eg. biodiesei).
in some embodiments, an algal s or component thereofoi‘the invention is used in
preparirtigz-111011 proouetteg an i feeder feedtomponent).
BRIEF DESCREPTEON OF THE DRAWINGS
PCT/U82012/046696
Figure 1 depicts data generated during Sarge scale, i‘ieterotrophie algae biomass
production according to aspects of the invention.
Figure 2 shows the fatty acid profiie of aigae biomass harvested from l,
independent large scale algal cuitures.
Ui Figure 3 shows a eemposite fatty acid proiiie eta harvested biomass utilizing
materials and methods described herein.
BEFENI'HQNS
As used herein, "phospholipid" refers to err c compound having the i‘oilowing
i0 general stmemre:
wherein RE is a fatty acid residue, R2 is a fatty neid residue or MOE-L and R3 is a «H or
nitrogen containing eompound ehoiine (HOCHg’CHENYCHmOH’), ethanoiamine
(HGCHzCHgNiig), innsitoi or serine. RE and R2 cannot anennsiy he OH. When R3 is
an ~OH; the compound is a diaoyiglyeerophosphaie, while when R3 in a nitrogen—containing
compound, the compound is. a atirie such as ieeithinF oephalin, phosphatidyi serihe or
piesmalogen,
A11 ”ether olipid” as used herein refers to a phesphoiipid having an ether bond
at position i the giyceroi backbone. Examples of ether phosphoiipids inoinde, but are not
iimited to” eh yieeyiphosphatidyicholine , ly50--aliiyiaeylohosphatidyiehoiine
(LAAPC‘), and nihyiaeyiphosphatidyleti’ianoiamine {AAPE}. A, ”non—ether phosphoiipid” is a
phosphoiipid that does not have an ether bond at position i of the nl backbone.
As used herein, the term "omega-3 fatty acid" refers to peiyunsaturaied fatty acids
that have the. finai doubie bond in the arbon chitin between the third anti fourth carbon
PCT/U82012/046696
atoms from the methyl end of the molecule. iting examples of omega—3 fatty acids
e, 5,8,1l,l4,l7«eicosapentaenoic acid (EPA), 4,7,1ll,l3,l(3,19ll-docosahexanoic acid
(DHA) and 7,} l),l3,lt),l9~docosapentanoic acid (EPA).
As used herein, the terms "triacylglycerld" "triglyceride” and "triacylglycerol ’ and
U1 “TAG” refer to is an ester derived from glycerol and three fatty acids, wherein "fatty acid"
refers to a carhosylie acid with a long unbrancliecl aliphatic tail (chain), which is either
saturated or unsaturated. l’alniitic acitl is one, non~limiting example of a. triacylglyceride.
As used herein, the terms "9/6 w/W {weight/weight) ” and "w/w %” and grammatical
equivalents re or to the amount (percent) of a given substance in a composition on
it) tzweight basis, For example, a composition comprising 50% w/W phospholipitls means
that the mass ofthe phospholipids is 50% of the total mass of the composition (ie 50 grams
ot‘phospholipids in lOO grams of the ition, such as an oil).
As used herein the term "algae” refers to a unicellular or rnulticellular organism
ly classified as plants, occurring in fresh or saltwater, autotrophic or heterotrophic, hut
l5 that lack true stems, roots, and leaves. As used herein the term "lietertitronhic” refers to an
organism that cannot size its own food and is dependent on organic substances (cg,
complex anal/or ‘imple organic nces) for nutrition, Thus, the term otronhic
algae" refer to an algae that cannot synthesize its own food and is dependent on organic
substances for nutrition. As used herein, the term "atitotrophic" refers to an organism capable
ol‘synthcsiz its own food from inorganic nces, using light: or chemical . The
use ol‘tlic term "algal” also relates to microalgac and thus encompasses the meaning of
Hnncioalgal.‘41 fl"The term H "
, "' 17.. v .17 . . ". .. algal ition refers to any composition that comprises algae,
such as an aquatic composition, and is not limited to the hotly ofW ater or the culture in which
the algae are cultivated. An algal composition can he an algal culture, algal hiomass, a
[\3 L!i concentrated algal culture, or a (lewatereil mass of algae, and can he in a liquid, semi—solid, or
solid form. A non—liquid algal composition can he bed in terms of moisture level or
percentage weight ot‘the solids. An "algal culture” is an algal composition that comprises live
algae, The term "algae" includes niacroalgae (commonly known as seaweed) and
microalgae.
(A! .
, As used herein, the terms ”algal biomass" or ”biomass" refers to a collection or mass
of algal cells grown in a given area or ecosystem at a given time. The area or ecosystem may
he a naturally occurring, environment (cg, body of water) or a synthetic environment tag, in
a l‘errnentor or hioreactor leg, open or closed».
WO 10090 PCT/U82012/046696
As used herein, the term "total fat” refers to the sum ol‘triglyeerides, phosphoiipids,
‘ present in a material. For example, ”total fat” content oiian algal
biomass refers to the sum of triglycerides, phospholipids, wax ester, and sterols present in the
biomass. in on, total fat includes both saturated and unsaturated fats,
U1 As used herein, the term "preservative" refers to an agent that extends the storage life
offend and non-food products by retarding or preventing deterioration of flavor, odor, color,
texture, ance nutritive value. or safetyu A preservative need not provide a lethal,
irreversible action resulting in partial or complete microbial eell destruction or ineapacit’at‘ion.
Sterilants, sanitizers, disinfectants, sporioides, oes and tttbereuloeidal agents provide
l 0 such an irreversible mode of , sometimes referred to as "bactericidal” action. in
contrast, a preservative can provide an inhibitory or haeteriostatie action that is reversible, in
that the target microbes can resume multiplication it~ the preservative is removed. The
principal ences between a preservative and a sanitizer primarily involve mode of action
(a preservative ts growth rather than killing microorganisms) and exposure time (a
presetyative has days to months to act whereas a sanitizer has at most a few minutes to act}.
As used herein, the term "yeast" and “yeast cells" refers to ettlraiyotie microorganisms
classified in the kingdom Fungi, having a. cell wall, eell membrane and intracellular
components. Yeasts do not form a specific taxonomic or phylogenetic grouping. tly
about 1.500 steeies are known; it is estimated that only 0/6 of all yeast species have been
describedrThe term "yeast" is often taken as a, synonym for S. corsair/Image, but the
phylogenetic diversity ofyeasts is shown by their placement in both divisions Asoomyeota
and Basirliomyeota. The g yeasts ("tine yeasts”): are fied in the order
Saeeharomyeetales. Most species of yeast reproduce asexually by budding, although some
reproduce by binary n. Yeasts are unicellular, although some species become
L! multieeilniar through the formation of a string; of ted budding cells known as
prettdoiz)?phae, orfizise ill/‘tvr’piicie. Yeast size can vary greatly depending on the species,
typically measuring 3___4 pin in diameter, although some yeast can reach over 40 pm.
As used herein, the terms ”st:lenium—enriehed yeast" and "selenized yeast” refer to any
yeast leg, Saeeharomyees eerevisiae) that is cultivated in a medium containing inorganic
(,2 selenium salts. The t invention is not limited by the um salt used. indeed, a
variety niuni salts are contemplated to be useful in the present invention includinO, but
not limited to, sodium selenite, sodium tte, cobalt seienite or eohalt selenate. Free
selenomethionine (’eg” not associated with a cell or yeast) can also he used as the um
sottree for selenium enriched yeast as yeast does incorporate this form of selenium. During
PCT/U82012/046696
cultivation, e of the chemical similarity between selenium and sulfur, yeast incorporate
selenimn in place of sulfur in what are normally Stiller-containing organic compounds within
the cell, A seleniuinwcontaining compound in such yeast ations is selenomethionine
which will be present in a form that is incorporated into polypeptides/proteins. The amount
U1 ol‘total cellular selenium present in the form of selenomethiunine in such preparations will
vary, but can be between it) and 109%, 20-60%, 50-75% and between 60 and 7594;. The
remainder of the organic selenium in selenized yeast ations is predominantly made up
of inteimediates in the pathway for selenomethionine hiosynthesis. These e, but are
not limited to, selenocystein’e, selenueystalhionine, pelenuhomuey’steine and seleno-
l 0 adenosylselen methionine, The amount of residual inorganic selenium salt in the finished
product is generally quite low t< 2%). However, the present invention is not limited by this
percentage, as preparations that contain more leg between 2 and 70%) or less (e.g., between
(ll and 2%) than this percentage are also encompassed by the ion.
As used herein, the term ”SElL—l’LEX” refers to a dried, nonviahle selenium—enriched
yeast leg, Sacehoromyces cerevisiae of accession number CNCM 1—3060, tion
Nationale De Cultures De Mieroorganismes (CNCM), lnstitut Pasteur, Paris, France)
cultivated in a fed-batch fermentation that provides incremental s of cane es
and selenium salts in a manner that minimizes the detrimental effects of selenium salts on the
growth rate of the yeast and allows for optimal ineorpora ion of inorganic selenium into
cellular organic material al nic selenium is eliminated (eg, using a rigorous
washing process) and does not exceed 2% of the total selenium content.
As used herein, the term "organic selenium” refers to any organic compound n
selenium replaces sulfur Thus, organic selenium can refer to any such compound
hiosynthesized by yeast, or it can refer to free organic seleno—compounds that are chemically
L! synthesized, An examnle of the latter is free selenomethionine,
As used herein, the term "inorganic selenium" generally refers to any selenium salt
(eg, sodium selenite, sodium selenate, cobalt selenite and cobalt selenate). There. are also a
variety of other inorganic selenium sources ( See e,g., those listed in the Merck index).
zed yeast may be generated using a source of inorganic selenium ing, but not
(,2 limited to, sodium selenite, sodium selenale, cobalt selenite, cobalt selenate, selenic acid,
selenious acid, selenium bromide, selenium de, selenium henal‘luoridec selenium oxide,
selenium oxylu'omide, selenium oxychloride, selenium oxylluoride, selenium sulfides,
selenium romide, selenium tetrachloride and selenium tetrai’luoride.
PCT/U82012/046696
As used herein the term ” east cell wall" also referred to as "YCW" refers to the cell
7 y
wall of a yeast organism that nds the plasma membrane and the intracellular
components of the yeast. Yeast cell wall includes both the outer layer (mainly mannan) and
the inner layer (mainly glucau and chitin) of the yeast cell wall. A function of the cell wall is
Ui to provide structure and protect the metabolically active cytoplasm. Signaling and recognition
pathways take place in the yeast cell wall. The composition of yeast cell wall varies from
strain to strain and according to (frowth conditions or” yeast.
As used herein, the term "purified” or "to purify” refers to the removal ol‘components
from a sam lie. For e, yeast cell walls or yeast cell wall extracts are purified by
it) removal of non—yeast cell wall components (egu plasma membrane and/or yeast intracellular
components); they are also purified by the removal of contaminants or other agents other than
yeast cell wall. The removal of nonyeast cell wall components and/or ast cell wall
contaminants s in an increase in the percent of yeast cell wall or components thereof in
a sample
As used herein, the term ”in vivo” refers to studies and“or experiments conducted
within a living sm, occurring Within a ical organism.
As used herein, the term ”in Vitro” refers to an artificial nment outside the living
organism and to biological processes or reactions that would normally occur within an
organism but are made to occur in an artificial nment ln vitro environments can
comprise, but are not: limited to, test tubes and cell culture.
As used herein, the term ”high—pcrformancc liquid chromatography” and the term
"l—lPLC" refer to a form ofliquid chromatography to separate compounds. The compounds
are dissolved in solution. Compounds are separated by injecting a plug of the sample mixture
onto the column. EFLC instruments comprise a reservoir of mobile phase, a. pump, an
injector, a separation column, and a detector. The presence of analytes in the column efi‘luent
is recorded by quantitatively detecting a change in refractive index, U V~VlS absorption at a
set ngth, fluorescence after excitation with a suitable wavelength, or electrochemical
response
As used herein, the term ”scanning electron microscopy” and the term ”SEEM" refer to
'30 use of a type oi“ electron microscope that images the sample surface by scanning it with a
high-energy beam of electrons in a raster scan pattern. The electrons interact with the atoms
that make up the sample producing signals that contain information about the samples
surface topography, composition and other properties such as electrical conductivity.
PCT/U82012/046696
As used herein, the term ”fixation agent” refers to a chemical that is capable oftixing
one substance to another in order to "fix", stabilize, or otherwise preserve the substance in its
current form :0 prevent the substance from degrading or otherwise changing. Often, fixation
agents are used in scanning electron copy (SEM) to prepare the sample. y
Ui fixation agent: as used herein, the terms "primary fixation agent" refers to the first fixation
agent used to ”fix" a substance._Seeondary fixation agent: as used herein, the terms
”secondary fixation agent" refers to the second fixation agent used to "fix” a nce.
Tertiary fixation agent: as used , the terms ”tertiary fixation agent” refers to the third
fixation agent used to "fix” a substance.
it) As used herein, the term ”analyte" refers to an atom, a molecule, a grouping of atoms
and/or molecules, a nce, or chemical constituent. An analyte, in and of itself cannot be
measured; ; aspects or properties (physical, chemical, hioiogicai, etc.) of the analyte can
he determined using an analytical procedure, such as HPLC. For example, one cannot
n ensure a "chair” (analyte-cornpnnent) in and of itself, hut, the height, Width, etc, of a chair
l5 can be measured Likewise, one cannot measure a inycotoxin but can e the xin
fluorescence that is related to its concentration.
As used herein, the term ”signal" is used generally in reference to any detectable
process that tes that a reaction has occurred (for example binding of antibody to
antigen). Signals can be assessed qualitatively as weii as quantitatively. Examples of tynes
of"signais" include, but are not d to, radioactive signals 'liuorintctr'ie signals or
metric product/reagent signals.
As used herein, the term "hioavailahility" re fcrs to the fraction ofa molecule or
component that is available to an organism or reaches the systemic Cireuiation. When a
molecule or component is stered intravenously, its hioavailahility is lit “/0 However,
[\3 L!i when a melee do or component is administered Via other routes (such as orally), its
hioavailahilily decreases (due to incomplete absorption and first~pass metabolism). in a
nutritional setting, bioavailahility refers to the rates of absorption and utiliaation of a nutrient.
Different fonns of the sante nutrient, for example, may have different bioavailabiiities,
As used herein, the term ”ef ective amount” re “ers to the amount of a composition
(A! t
, sufficient to effect beneficial or desired results. An efiectire amount can he administered
and/or combined with another al in one or more administrations, applications or
s and is not intended to be limited to a particular tornntlation or administration route,
2012/046696
As used herein, the term ”digest" refers to the sion od, ut‘ts, or other
organic compounds into absorbahle form; to soften, decompose, or hreals: down by heat and
moisture or chemical action,
As used herein, "digestive system" refers to a system {including gastrointestinal
Ui system) in which digestion can or does occur.
As used herein, the term tuffs" refers to rna.terial(s) that are consumed by
mammals (e,g,, humans and animals) and contribute energy and/or nutrients to a manrmal's
diet. Examples of leedstufts include, but are not limited to, Total Mixed Ration (TMR),
foragds}, pelletts), eoneentratets), premix(es) eoproduett’s), graints), distiller ),
l0 molasses, tibert’ls), fodderts) grass<es), hay, kernelt'sft, leaves, meal, solublets) and
supplentent(s).
As used herein, the terms "food ment“ "dietary supplement” "dietary
supplement composition“ and the like refer to a food product formulated as a dietary or
nutritional supplement to he used as part of a diet. Exam lary dietary supplement
compositions are bed herein.
As used , the term l" refers to those ot‘kingdom Animalia. This
includes, but is not limited to livestock, farm animals domestic, animals, pet animals, marine
and freshwater animals, and wild animals.
As used herein, the terms istration” and the term ”athninistering" refer to the
act of giving a substance, ing a drug, g, or other agent, or therapeutic treatment
to a subject tag, a subject or in Vivo, in Vitto, or ex ViVO cells, tissues, and organs).
Exemplary routes of administration can be through the eyes (ophthalmic), mouth (oral), shirt
(topical or transdermai), nose (nasal), lungs (inhalant), oral mucosa (buoeal), ear, rectal,
vaginal, by in'eotion (eg, intravenously, subcutaneously, mtratumorally, intraperitoneally,
[\3 L!i etef) anti the like.
As used herein, the term "eo—administration" and the term ”eo-administering" refer to
the administration of at least two agentt's) or therapies to a snbj eet and/or material (egg,
feedstuii’), Co~adtninistration of two or more agents or therapies can be concurrent, or a first
agent/therapy can be administered prior to a seeond agenfltherapy.
(A! e
, As used herein, the term "treatment" refers to measures taken that facilitate the
improvement and/or reversal of the symptoms ol’disease. The term "treatment” refers to both
eutic treatment and propl‘tylaetie or preventative measures. For example, subjects that
may 1oenefit from treatment with compositions and methods of the present invention include
PCT/U82012/046696
those already with a disease and/or disorder as welt as those in which a e and/or
disorder is; to he p evented (cg, using a prophylactic treatment of the present invention).
As used herein, the term "at risk for disease" refers to a subject that is predisposed to
experiencing a particular disease, This predisposition may he genetic (cg, a particular
U1 genetic tendency to experience the disease, such as heritable disorders), or due to other
factors (eg age, weight, environmental conditions, exposures to detrimental compounds
present in the SthV: onment, etc).
As used herein, the term "disease”, the term ”infection” and the term logical
condition or response" refer to a state, signs, anti/or symptoms that are associated with an
l 0 impairment of the normal state of a living animal or of any of its organs or tissues that
interrupts or es the performance of normal functions, and may he a response to
environmental factors (such as malnutrition, industrial s, or climate, including
mycotoxicosis), specific infective agents (such as worms, hacteria, or viruses), to inherent
defect of the organism (such as various genetic anomalies), or combinations of these and
other factors.
As used , the term ”suffering from disease“ refers to a subject (eg, an animal or
human subject}, that is experiencing a ular disease and is not d to any particular
signs or symptoms, or disease.
As used herein, the term " refers to any detrimental: deleterious, harmful, or
otherwise negative tt{s) on a subject, a cell, or a tissue as compared to the same cell or
tissue prior to the contact or administration of the toxin/ toxicant.
As used herein, the term "pirannaccuticai compositionH refers to the combination of
an active agent with a carrier, inert or active, making the composition especially suitahic for
diagnostic or eutic use in Vitro, in Vivo or ex .
L! As used herein, the term "pharmaceutically acceptahie” and the term
”pharn‘iacoiogicaliy acceptable" refer to compositions that do not substantially e more
known adverse reactions than known beneficial reactions.
As used herein, the term ”inoculation” refers to the act of introducing a
rganism or suspension of microorganisms (cg, algae, yeast, fungi, bacteria, etc) into
1;.) a culture medium. lnocuiation is the act or process or” introducing something into an
environment in which it will grow or reproduce.
As used herein, the term "lt’lOCultml" and the term "pre-inoculun1” refer to cells used
in an inoculation, such as cells: added to start a culture.
m. (a)
PCT/U82012/046696
As used herein, the term ”centrifugation" refers to the ting of molecules by size
or y using fugal forces generated by a spinning rotor that puts an obj ect in rotation
around a fixed axis, applying a force perpendicular tn the axis. The centrifuge werke using
the sedimentation principle, where the centripetal acceleration is used to evenly distribute
U1 substances oi“ greater and lesser density into ent 'tayers of density.
As used herein the term "concentration" refers to the amount oi" a substance per
defined spacer, Ce-ncentration usually is sed in ternn; of tnase per unit ofvoiutne. To
dilute a solution, one must add more solvent, or reduce the amount of solute teg. by
selective evaporation, spray drying, freeze drying, egg, coneentra etl yeast cell wall extract or
i 0 concentrated ntoditied yeast cell wall extract). By contrast, to trate a solution, one
must add more solute, or reduce the amount of t.
As used herein, the terrn "layer“ refers to a usually horizontal deposit organized in
stratum of a material thrrning an oy erlying part or segment obtained after separation hy
fugation in relation with the detteity properties of the material.
As used herein, the tern: ”harvest“ refers to the act of collecting or bringing together
materials that have been produced (e.g, bringing together materials produced during yeast
productionfu
As used herein, the term "drying” refers to spray drying, fieeze drying, air drying,
vacuum drying or any other kind of process that reduces or eliminates; liquid in a substance.
As used herein, the term ”spray drying” refers to a commonly used method oi‘drying a
substance containing liquid using hot gas to evaporate the liquid to reduce or eliminate liquid
in the substance, in other words the material is dried by way of ng or atnrni7ing into a
draft, of heated dry air.
AS used herein, the term e—drying" and the term "iyophilization" and the term
L! "cryodesiccation" refer to the removal of a solvent from matter in a frozen state by
sublimation. This is accomplished hy freezing the material to he dried below its eutectic
paint and then prnyiding the latent heat of sublimation Precise control 0f heat input permits
drying front the frozen state Without product melt—hack in practical application, the proceee
is accelerated and eiy controlled under reduced pressure ions.
(,2 As used , the ternr "dry free flowing powder” refers to a free flowing dry
powder, eg. a powder that can be poured from a, container” bag” vessel etc without hindrance
of large clumps.
As used herein the term "grinding” refers to reducing particle size by impact,
shearing, or attrition.
PCT/U82012/046696
As used herein, the term ”sample" is used in a broad sense including a specimen or
e ed from any source, as well as biological and environmental samples.
Biological samples may he obtained from animals ding humans) and encompass fluids,
solids, tissues, and gases ical samples include blood products, such as , serum
U1 and the like. Environmental samples include envirom’nental material such as surface matter,
soil, water, crystals and industrial samples.
I) IAILED DESCRIPTION OF THE lNVEN't‘lON
This invention relaes to compositions comprising high lipid content algae and
l0 methods of making and. utilizing the same. in particular, the ion relates to high lipid
content algae biomass and algal lipid materials derived from the same, methods ofntahing
the same, as well as to biot‘uels (e.g., hiodiesel) and dietary compositions leg, animal feeds}
comprising or made from the same. itions and methods of the ion find use in a
variety of applications including biofuel, dietary (egg human and animal nutrition),
therapeutic as well as research applications.
Accordingly, in one aspect of the invention, there is ed a process for the
ation or" an algal biomass containing elevated amounts tag, on a \v/vv basis) of total
fat. For examples, as described herein, in some embodiments, the invention provides a
method of generating an algal biomass containing a desired, high level of total fat content
(cg, greater than 66% total fat, in contrast to conventional methods that generate algal
biomass containing a significantly lower level of total fat content (eg 60% or less total fat».
A great challenge of algal~hascd hiolncl (cg, hiodioscl) is to ensure that the 1oiomass is not
made at the expense of more energy than is obtained in the final fuel product. Accordingly,
in some embodiments, the invention provides a method of generating an algal biomass
[\3 Ln containing r than 65% total fat. in some embodiments, the invention provides a method
ot‘generating an algal biomass containing greater than 66% total fat. in some embodiments,
the invention provides a method of generating an algal biomass containing greater than (37%
total fat. in some embodiments, the invention provides a method of generating an algal
biomass containing greater than 68% total fat. in some embodiments, the invention provides
(,2 r
v a method of ting an algal biomass containing greater than 69% total fat. in some
embodiments, the invention provides a method of generating an algal biomass containing
greater than 76% total fat. in some en’tbodiments, the invention provides a in ethod of
generating an algal s ning greater than 70% (e.g., greater than "ll, 72, 73, '74, '75,
76, 77, 78 79, 8'0, ill, 8;, 83, 84, 35, 86, 87, 88, 89, 93% or mo e) total fat on a 'w/w basis,
PCT/U82012/046696
in some embodiments, the method utilizes a closed hioreactor system ( 9g, 21 1131111911101),
although the 1011 is not so limited19g , in 391119 unhodiments, open hioreaetors may he
utilized). ln a1319-9T9r19d 9111bo<li1neut, growth of an algal T omass ofthe invention is
ted under aseptic conditions. in another preferred 911'1hodi111911t alga9 are grown (91g,
U1 to generate an algal biomass containing a high fat content (9.5.3.1 greater than 679/6 fat» in a
fed-hatch process,
in some embodiments, the invention provides a method of culturing algae to produce
an algal biomass comprising a desired, high total fat 9111119111 (9g 67% or more total fat) as
deseiih9d111 Examines i and14 For 9xa11111i9, in 1101119 embodiments, the i11'v9ntion provides a
l 0 method of culturing algae comprising culturing the algae in a stepwise manner so as to
produce an algal s eomprisingaa d911nd hisIl1 total fat content (9.1167041 111 more total
fat). in some embodiments, a stepwise process for culturing algae comprises thawing 21
stored strain of algae and adding (9g aseptically) the thawed algae to a 1L shake flash
eontain medium1‘unprising a carbon source (9g sugar (9g, glueose‘3 ‘3, yeast extract and sea
salt. in some embodiments, the carbon source is present in a concentration of 50 g/L, the
yeast extract is present in a concentration of it) g/‘L and/or the sea salt is present in a
concentration oi‘I-l g/L, in some embodiments“ the ill; shake flask ning algae and
medium are maintained at 30 EC and shaken (eg, at about 11111-400 RPM) until surh time that
the algae have entered exponential growth phase but have not fully ed the carbon
source (9g, sugar (9g, e». ments conducted (luring pment of
embodiments of the invention have determined that the algae enter exponential growth but do
not fully dc lete the carbon source (9g, sugar (9,511., glueose)) at a time period between 72—
144 hours, Thus, in some ments, algae cultivated in a lL culture flask at 30 C for 72-
l44 hours at UG—éllli} RPM ,250 RPM)111 medium 9oinprising a carbon source
£11 (91g, sugar (9.15,, 111111111593), yeast extract and sea salt is used to inoculate a first seed stage
culture (9.31., in a larger vessel (9g, 40, 27 or iii L vessel/i). in some embodiments, the
culture inedir 'usedin a first 599d stage composes a caihon 5011199 (9.0
g, sugar (9g,
glut;osel) yeast extract magnesium sulfate, 99131111111 rhloride and/or magnesium 1hlorid9.ln
a pi‘efened embodiment the 1.11lture medium used111 9 hrst seed stage comprises about fillg/L
(,2 of a carbon souree (9.11., sugar (9.5.3., 11111903911}, about 7.5 gfL 921st extract about {1 15 g/
inagn9siuin suliat9,ahou1 0 l5 g/L caldum chloiid9 ‘ndjorit) 15 g/L magnesium chloride. in
some embodiments, the first seed stage cultureis 11111 atlll ( under airflow and agitation
conditions so as to maintain dissolved oxvgen at about7iii/.1 (9.11,,8, 9, ll), ll, 12, 13,
149.41), gh lower and higher dissolved oxygen conditions may be utilized. in a prel91‘retl
PCT/U82012/046696
embodin‘ient, the first seed stage culture is run at 38 {2 outlet airtlow and agitation conditions
so as to maintain dissolved oxygen at about 10%. in some embodiments, the first seed stage
e containing ‘ lgae and medium are maintained at 30 C and cultivated until such time
that the algae have entered exponential growth phase and at least 20 g/l, of carbon source
U1 (eg sugar leg, glucosel) has been consumed but the carbon source has not been fully
depleted. Experiments conducted during development ol‘emhodiments ol‘the invention
determined that the algae enter exponential growth, consume at least 20 g/L of carbon source
(eg, sugar (eg, glucose)) but do not luiiy deplete the carbon source leg, sugar (e.g.,
gitteose)) at a, time period between 24-48 hours after inoculation of ti e l‘irst seed stage
l 0 culture, in some embodiments, algae cultivated in first seed stage culture at 30 C for 2-41—48
hours in medium comprising a carbon source (eg, sugar (cg, glucose», yeast t,
magnesium sulfate, calcium de and magnesium chioride are used to ate a second
seed stage culture in yet a larger vessel (eg, 2000 L vessel), In some embodiments, the
culture medium used in a second seed stage culture comprises a carbon source (eg, sugar
(eg, giucosell, yeast extract, ium sulfate, calcium de and/or magnesium
chloride. In a preferred embodiment, the culture medium used in a second seed stage culture
comprises about 50 g/l. of a carbon source {eg sugar (egg glucose/i), about 7.5 g/L yeast
extract, about 0. i5 g/is magnesium sulfate, about 0. l5 g/L calcium chloride and/or ll. i5 g/l..r
magnesium chloride. in some embodiments, the second seed stage culture is run at 30 C
under airtlow and agitation conditions so as to maintain dissolved oxygen at about: 7--l 5%
leg, 8., 9, l0, l l, l2 l3, ill-92;), although lower and higher dissolved oxygen conditions may
be utilized. in a preferred cmhmlimcnt, the second seed sta0c e is run at '30 C undo
airflow and ion conditions so as to in dissolved oxygen at about iOQ/éi. in some
embodiments, tl e second seed stage culture containing algae and medium are maintained at
L! 30 C and cultivated until such time that the algae have entered exponential growth phase, and
at least 20 g/L ofcarhon source leg, sugar {e.g., glucose» has been consun‘ied, but the
carbon source has not been litlly depleted. Experiments conducted during pment of
embodiments of the invention determined that the algae enter exponential growth, consume at
least 20 g/L ofcarhon source (eg, sugar (cg, glucosell but do not fully deplete the carbon
(,2 source leg, sugar leg, glucose» at a time period between 2448 hours alter inoculation of
the second seed stage culture. in some ments, algae cultivated in second seed stage
culture at 30. C for 24—48 hours in medium comprising a carbon source (eg, sugar (eg,
glucoseD, yeast extract, ium sulfate, m chloride and magnesium chloride are
used to inoculate a large scale vessel leg, ”@300 L, i20,t300 L, 220,990 L or larger vessel
PCT/U82012/046696
(e g, a main fermentorl) containing medium used for thither culturing/termentation of the
algae. in some embodiments. upon transfer ofthe s-cond s2ed:tage e to the large scale
vessel leg. main fermentor). the culture medium (eg, the hatched medium) present in the
latge scale vessel (sag, i’nain ferinentor) comprises a carbon source (2.21> sugar leg.
U1 glucosefi. yeast ex. tract, magnesium sulfate, urea, calcium chloride, magnesium chloride
and/or monopotassiuni phosphate. In a preferred ment. the culture medium used in a
large scale (e.g.. 70.000 L. 120,000 I... 1220.000 l. or larger vessel , main fermentorll
culture ses about ’50 g/L ol‘a carbon source (eg, sugar (e.U about 7.5 g
g. . glucosel),
yeast t. about 4.0 g/L ium sulfate. about l g/L urea, about 2 g/L calcium
l 0 chloride. about 2 ml. magnesium chloride and/or about 0.25 g/l. mono-potassium phosphate.
in some embodiments, the large scale culture is run at 30 C under airflow and agitation
conditions so as to maintain dissolved oxvgen at about7 -l59/:2 (e9 9
. 8, ll) ll l2. l3,
149/21). although lower and higher dissolved oxygen conditions may be utilized. in a preferred
embodiment. the large scale culture is tun at 30 C under airflow and ion conditions so
as to maintain dissolv ed oxygen at about ltl%. in a preferred embodiment, the carbon source
(e.g., sugar (e.g , glucose»is maintained at to 1:1 tor a period oi time (e.g. l or more days
(2g... .2. 3. 4, 5. 6. 7, 8, 9. l0. ll. 12. l3, 14 or more days (ea. using a fed-hatehprocessll.
For example, in some embodiments. after a desired amount of e has been consumed by
algaein the large scale t(eg, after about 203C- g/‘L l-l glucose has been consumed by
the algae in the large scalev' essel (c.g” atter ill gl of 17lu2os2 has been consumed1) nineosc
and tch feeds are started. Experiments conducted during development of embodiments
of lVLntitun determined that the fed—batoh foods be added for about 34 hours. although
shorter leg. about 32, 28. 24, 20 hours or fewer) and longerafe 36 38 42. 46 so 84
96. l2l8, 1120, l3’2. lit-4, 150’. loll. hours or more) time periodsémay he used. in further
L! preferred embodu-nnts upon 2empletion ot the fedbat2h process 2ultivaticn of the alrga2 is
continued in the large scale vessels until all nutrients are letuntied/consumed from the
medium. Experiments conducted during development 21. embodiments of the invention
determined that tl1et1utrients are depleted trom the medium b2tween about l2 and 24 hours
after cessation of tl1 fed—batchinrceess. in some 211rbo(iii”tents the algal biomassis harvested
(,2 from the large scale culture mediunubroth and utilized as described herein in some
embodiments. the large .oale culture broth is centrifuged to obtain the algal biomass. in
some embodiments, the large 52ale culture brothis cooled prior to centrifugation. Al tlmugh
an tanding of a mechanism is not needed to practice the invention and the invention is
not d to any particular mechanism ofaction. in some ments. chilling the culture
WO 10090 PCT/U82012/046696
broth increases the density of the algal biomass comprising e evated levels of total fat tag,
lipids/oil) and aliows a larger recovery ot’the biomass than is achieved in the absence of
chilling the culture. broth ( Sec, e.g., Exampic 3)., The invention. is not. limited by the.
temperature to which the large scale culture is chilled prior to centrifirgarion. in some
Ui embodiments, the large scale culture is chilied to a temperature between 0-50 C, between 5-
40 Ce 5-25 C, 5-15 C or 5-10 C.
'l‘hns. the invention utilizes both batch and tch modes of culturing algae (egg
alone and/or subsequent to a first and/or second seed stage) in order to generate an algal
s that: contains a desired fat content (tag a, fat content greater than 67%). The
invention is not limited by the individual components present in the media used in either the
batch or fed—hatch modes. in some embodiments, culture media present at the time of
inoculation ot‘a main fermentor (e.g., 70,000 L, 120,000 L, 220,000 L ) contains
medium with an initial ratio of nitrogen osnhorns (P):notassinm (K) of46213:8.5. ln a
preferred embodiment, the N :l’2K ratio is the same in the hatch and fed—hatch culture modes
in some embodiments, the ratio of magnesium (Mg):calcinm (Ca) is 3:1 in culture media
used in both hatch and fed—hatch modes. in another embodiment, the ratio of chloride
(€12):solfate (SO-4)) is l:‘t in culture ntedia used in both hatch and fed-hatch modes. in some
embodiments, the ratio of sulfate (“804):phosphate (1’04) in media at the time of ation
ot‘a main fermentor (tag, 70,000 L, 0 L, 220,000 1;. ) is 16:1. in some
etnhodintents, the total ratio of sulfate (804)2nhosphate (P04) that has been batched and tied,
at the end of a full culture (cg, including inocolumfl first seed stage, second seed stage and
main ternicntor cultures) that generates an algal biomass containing a desired fat content
‘3“In 00. than 67% fat) is 5.3:l. in some embodiments, the ratio of chloride
., greater
(C,W2):}9hnsphate (PO-4) in media at the time of inoculation of a main fermentor (cg, 70,000
[\3 L!i L, 130,000 1-, 220,000 L vessel) is 16:}, in some embodiments, the total ratio of chloride
(C12):phosphate (1304) that has been batched and tied at the end of a lull e (eg
including inocuhini, first seed stage, second seed stage and main fermentor cultures) that
generates an atgat biomass containing a desired fat content (eg, r than 67% fat) is
.311.
(A! i
, As described in Example 2 below, the invention also provides a composition
comprising an algal biomass reg”, a dried algal biomass (ego generated according to a
method described herein» containing a desired amount or" total fat and/or other components
For example, in some embodiments, the ion provides an algal biomass (eg, a dried
biomass) containing r than a % total fat (out; greater than about 6894;» totai fat, greater
PCT/U82012/046696
than about 699/; total fat, (greater than about 7094o tot3i tat, r than about 7l9t> total lat,
greater than about 72% total fat, greater than about,-96 total tat, greater than about 74% total
fat, greater than about 75% total lat, greater than 094) total tat, greater than about 77%
total fat, greater than about, 72"% total Fat or higher amount of total fat) ln some
U1 embodiments, an algal biomass (e.g, containing r than (179A) total tat)is dried such that
the biomass oontains less than 5"/o moisture egt less than 4.5% moisture, less than 4%
moisture loss than 3.5% moisture. loss than 3% rootstore less thanfl.-5% moisture, loss than
29/61rtoisture,or less than l.59o re) in some embodiments an algal biomass of the
in ’tlilllO‘ill:I..g, a dried s containing less than 5% moisture) contains about 170-251)
l 0 mg’g or more dooosaltexaenoic arid (DHA)teg about 170180 mg/g DHA about 180— lQCI
mg/‘ggl)HA, about l90200 mgIg1,)HA, about 2002th mgg DH,A about 2i 0220 mgr/g
DHA, about 220230 rug/g DHA, about 230-240 mg/g DHA, about 240250 mg/g DHA, or
more than 25% mg/g DHA). in some embodiments, an algal biomass of the invention te.g., a
dried biomass containing less than 5% moisture) contains about Mil—400 1ngg or more
oahnitio acid (lUPAC name: hexadeoanoie acid (eg, abo it 156-200 rug/g, about 200—225
mgr/g, about 225--520 hog/g about 25.0-275 rug/g, about 0 mg/g,about 300325 mg/g,
about 325-SSJII1-thg, about 350‘ 33175 tug/g, about 3.75 403:1" or more than 400 mg/g)‘ in
some embodiments, an algal biomass of the invention (eg, a dried biomass containing less
than 5% moisture) contains about Still—600 tug/g or more total fatty aoids (e. 3;, about 300—350
tog/g, o490 mg/g,about 40t)456}, trig/g, about 450-5,00 mg’g, about 500--550 rug/g;,
about 550—('meng‘gor more than 60.0 mg/g tatty acids/l} in some embodiments an algal
s of the invention (og, a dried s containing less than 5% moisture) contains
less than about i594; protein (fog, less than about l49/i; protein, toss than about l3°A; n
less than about‘t 2% protein, less than about i l°o protein, less than about M393 protein, less
L! than about 9vb p1otein,or lessthan about 8% protein).
The invention is not limited by the strain or species otalgae utilized in the methods
and compositions described hermein lndeed, a vaiietyooatlgaae find use in theintention
including, but not limited to, one or more species of the genus Thruwaowyizum in some
embodiments, the algae is a species of the genus Chime?to in some embodiments, the algae
(,2 is a species of the genus , chizmhvtItrimn. in some embodiments, the algae is a species of the
genus Crivplhecodinizmt. in some embodiments he algae is Tomznlooaymmt wanton
T71mattochyirium roseum, Ifirzzuttochviiwm (tweenI,C eoodrmum submit, and/or
[lit/‘Lly'lldul’Zl/l}IIIm so in a red embodiment ooizwrmm Zlmnynum is utilizedin the
methods and compositions bed herein. The invention is not: limited by the type ot‘lipitls
.o;an
PCT/U82012/046696
produced by a process to generate an algal biomass with elevated levels ol‘lipids disclosed
herein. in some embodiments, the lipids generated by a. process of the invention include, but
are not limited to, myristic acid, palmitic acid, oleic acid, linoleic acid, doccsapentaenoic acid
(GPA), ahesaeuolc acid (DHA), and stearic acid. "l‘hese lipids have been useful for
U1 both animal and human health, for prevention of various es such as cardiovascular" and
atory diseases and in infant nutrition for proper brain development and retinal vision
in children.
in another embodiment, the ion provides a process for production of an algal
biomass containing elevated levels (cg, greater than 67%) oi‘tolal fat from an algae species
l 0 Cog” Schizochytrium limacinurn), wherein the process comprises culturing algae in a first
feed hatch vessel comprising medium (are, comprising about 50 g/ll. of a carbon source (eg,
sugar reg, glucosefl, about 75 g/L yeast extract, about 0. l5 g/L magnesium sulfate, about
0.l5 g/L calcium chloride and/or 0. l5 g/L magnesium chloride), tiransieiring (e01,
aseptically) the first feed hatch culture to a second seed hatch. culture mediumteg,
comprising about 50 g/L of a carbon source leg, sugar (cg, glucoseljt, about 75 g/L yeast
extract, about 0. l5 g,L magnesium sulfate, about 0.15 g/L calcium de and/or 0.l5 g/L
magnesium chloride}, transferring (cg, aseptically) the second seed hatch culture to a large
scale e vessel containing medium (eg, a main term-enter (e.g,, 70,000 L, 120,000 L,
220,000 L vessel, containing, for example, medium sing about 50 g/L ol‘a carbon
source (cg, sugar (cg, glucose», about 7.5 sails yeast t, about 40 g/L magnesium
sulfate, about l g/L urea, about 2 g/L calcium chloride, about 2 g/ln magnesium chloride
and/or about 0.25 g/L monopotassium ate), wherein the glucose level of the large
scale culture vesse is maintained at 10 g/L using a fed-hatch process, wherein the algal cells
are harvested from the large scale culture between l2~24 hours after ion of the let —
L! batch process after all of the nts have been removed"consumed from the medium.
Another ment of the invention provides a process for production ot‘an algal
biomass containing ed levels (eg. r than (37"775) of total fat from an algae species
(eg, Sclrizochytrium lirnacinum), wherein the culture medium (cg, during each stage of
fermentation (cg, first seed stage, second seed stage and/or hatch culture (fed—hatch)
(,2 cultivation stagell comprises a carbon source tea, a sugar), yeast extract, a phosphate source
(e.g,, monopotassium phosphate, magnesium sulfate and/or zinc sulfate), a nitrogen source
(eg, urea), magnesium chloride, and/or calciun‘i chloride. In a preferred en‘ibodiment, the
invention es a process for production of an algal biomass containing elevated levels
(ewg greater than "'7‘3/13) of total fat from a strain ae whe ‘ein the culture medium leg,
2012/046696
during each stage of fermentation (6.3;, first seed stage, second seed stage and/or batch
culture (fed-hatch) cultivation stagej) comprises sugar, yeast extract, nionoootassium
phosphate, magnesium sulfate, zinc sultate}, urea, magnesium de, and/or calcium
chloride. However, the invention is not limited by the type of nutrient utilized in a culture
U1 medium in WI .cli algae are grown. In some ettthodiments, one or more carbon sources are
added to the medium. Examples of carbon sources include, but are not d to,
carbohydrates such as glucose, fructose, xylose, saccharose, maltose or soluble starch as well
as oleic acid, fats such as soybean oil, molasses, glycerol, mannitol, and sodium acetate,
cotton see flour, glycerol, molasses and corn steep liquor. in son e embodiments, one or
l 0 more nitrogen sources are added to the medium, Examples of en sources include, but
are not d to, neutral nitrogen sources such as peptone, yeast extract, malt extract, meat
extract, casamino acid and corn steep , c nitrogen sources such as sodium
glutamate and urea, or inorganic nitrogen sources such as ammonium acetate, ammonium
e, ammonium chloride, ammonium nitrate and sodium sulfate. in some embodiments,
one or more phosphate sources are added to the medium. Examples of phosphate sources
include, but are not limited to, potassium phosphate and potassium dihydrogen ate,
inorganic salts, such as ammonium sulfate, sodium sulfate, magnesium sulfate, iron sulfate,
zinc sulfate, and copper e. ln some embodiments, magnesium chloride, calcium
chloride, and/or vitamins are included in the culture .
The invention is not limited by the amount (cg, concentration) of each ot‘tltcsc
components in the culture medium. in some embodiments, an amount is utilized that is not
harmful to algal growth. in a tire lorrcd embodiment, the amount (cg, concentration and/"or
ratio) ofcach medium ingredient is set at a level (egg during each stage of tation (cg,
first seed stage, second seed stage and/or batch culture {fed—hatch) cultivation stage) that
L! promotes the formation of higit fat content algae (eg, an algal biomass comprising 67% or
greater fat content). in some embodiments, the carbon source (eg, sugar) is present in
culture medirm at about 2t) to 120 grams per liter oi‘medium. in other embodiments, the
carbon source (cg, sugar) is t in culture medium at about 50—70 grams per liter of
medium. in still other embodiments, the carbon source (eg, sugar) is present in culture
(,2 medium at about 40 to 60 grams per liter of medium. in a preferred ment, the carbon
source (e.g., sugar} is present in culture medium at about 50 grams per liter of medium. in
some embodiments, the ratio of urea to n‘ionopotassium pl’iosphate (i,trea:l(ll2l304) is
between about Sill leg, about 4.5:O.l; 4:025; 3:025; 420.3; 5:03; 510.5; 420.5; 3:05; 2:05;
or l:ll.5); although higher and lower ratios may he used (eg, lzl, l12, l:3 etc.) in a
ix.) ix}
PCT/U82012/046696
ired embodiment, the ratio of urea to monopotassium phosphate in culture medium is
421‘ in some embodiments, a culture medium does not contain sodium chloride. in other
mentse a culture medium contains sodium chloride. in some embodiments, the ratio
of magnesium sulfate (:hllgSOAl):ealoium chloride tCaClZ} is l:l. in some en'ihodiinents. the
UH ratio gnesium sulfate (MgSO4):calcium chloride {CZECH} is i2. indeed, a y of
ratios of magnesium sulfate (MgSOLl):oalcium chloride (CaClE) may he used including, but
not limited to. 1:1; lzl.125; 111.5; l:l.75; lift; 1:2.l25; 1:22.25; 112.5; 2511; 2.25zl; 232521;
2:1; l.75:l; l.5:1; 1.25:1 or 1.l25:l. In a preferred embodiment, the ratio utimagnesium
suliate {MgSOd-lwalcium de (CaClZ) in a first seed culture medium is l:l. in r
it) preferred embodiment the ratio of magnesium sulfate gS(_)/il):ealcirtnt chloride (CaClZ) in
a second seed culture medium is 1:1. in yet another preferred embodiment, the ratio of
magnesium sulfate (h/IgSlemalcium chloride tCaClE} in a large scale culture medium (cg,
main t‘ertnentor reg, 70,0th L, 120,000 L, 230,000 L vessel) also referred to as a third
culture medium herein) is l22.
In a turther red ment, after preparing the medium, the pit of the medium
need not be adjusted. For example. during a se fermentation process ofthe invention
the pll of the culture medium in which algae is grown need not be adjusted. Although an
understanding of the mechanism is not necessary to practice the invention and the invention
is not limited to any particular ism ot‘action, in some embodiments, sterile and/or
aseptic conditions of the stepwise fermentation process of the ion negates the need to
adjust the pH of the culture medium during fermentation. in some embodiments the pH of
the culture medium is between 4.0 and 65. Cultivation oi‘thc algae during a se
tatinn process of the invention may he carried out at a temperature between in and all)
C, preferably 17 to 35 C, and most preferably around 3!”) C. Cultivation may he performed
[\3 L!i by aeration—agitation culture, shaking culture, stationary culture or the like. in a preferred
embodiment, al, 'ae are cultured under conditions such that dissolved oxygen is maintained at{1C
or slightly above 10%.
In some embodiments, the invention provides a food, tieedq nutritional or therapeutic
supplement ctmprising all or a portion of an algal biomass“ (e.g., a dried algal biomass
(A! 1
, described herein and/or generated according to the methods and compositions described
herein) comprising ed levels 1:e. g, greater the s 7-1II 0/4)) ol‘total fat. For example in some
embodiments, the ion provides a food, feed, initritional or therapeutic supplement
comprising a spray dried algal biomass comprising elevated levels (egg, greater the 67%) of
total fat. in oti er ments” tl e invention provides a food, feed, nutritional or ti erapeutic
a} a}
PCT/U82012/046696
supplement con‘iprislng lipirls ted and/or isolated from an algal biomass comprising
elevated levels tog, grater the 67%) oftotal fat, The invention is not limited by the type of
lipid extracted and/or isolated from an algal biomass comprising elevated levels ( e.g, grater
the 67%) of total fat. in some en’rbodiments, the lipids comprise rnyristic acid, palniltic acid,
Ui oleic acid, linoleic acid, alpha—linolenic acid (ALA), stearidonic acid (SBA), eicosatrienoic
acid, eicosatetraenoic acid, eicosapenlaenoic acid , tlocosapentaenoic acid (DPA)
clupanorlonio acitl, docusabexaenoic acid (DHAL tetraocsapentaenoic acid, and/or
tetracosahexaenoic acid, in a preferred embodiment, the lipids comprise DHA anti/or
palmitic acid,
it) in some embodiments, the invention provides a process for the preparation ot‘lipitls
(eg, those sed herein (cg, docosahexaenoic article) comprising: culturing an algae
strain (eg Schizocizyrrz'um Zimacimtm) in a first culture medium (eg, containing> 50 g/L of a
carbon source (eg, sugar (eg, glucosei), ll) g/L yeast extract and 4 g/L sea salt) and
incubating the culture at a temperature in the range of 25—35 C for a periorl of about 72~ l 44
hours; transferring the e to a second culture medium (cg, containing 50 g/L oia carbon
source leg, sugar leg, glucose», about 7.5 5311. yeast extract, about lilo” g/L magnesium
e, about 0. l 5 gi calcium chloride anti/or 0,15 g/L magnesium chloride) and incubating
the culture at a temperature in the range of 25—35 C for a period of about 24-48 hours;
transferring the culture to a third culture medium (cg, containing 50 g/L of a carbon source
(eg, sugar (cg, glueoscfi, about 7.5 g/l. yeast t, about: (HS g/L magnesium sult‘aic,
about 0. l5 g/l. calcium chloride and/or (ll 5 g/L magnesium chloride) and incubating the
culture at a temperature in the range of 25-35 C for a period of about 24—48 hours;
iratisierririg the culture to a fourth cu liure medium (eg containing 50 g/L ofa carbon source
(cg, sugar (cg glucose», about 7.5 g/l. yeast extract, about 4.0 g/l; magnesium sulfate,
[\3 L!i about l g/l... urea, about 2 g/L m chloride, about 2 g/L magnesium chloride r about
0.25 g/L nronopotassium phosphate) and inc ubating the culture at a temperature in the range
ol‘25u35 C (cg, 3C5 C) for a time period ut 24-492 hours (cg, about 36, about 38,
about 42, about 45, about bl) about 72., about 84, about 96-, about
, lllli, about 120, about 132,
about l44, about lilo, about lo8, about ltitl or about l92 hours); separating the cell biomass
(A! i
. from the culture; and extracting lipids from the s.
in some embodiments, algae cultures (eg. grown to produce an algal biomass) are
grown in suitable volumes and vessels, ranging from ill-ft ml to hundreds of thousands of
liters, in flasks or large fermentors, using various nt media as described herein.
in yet r , the separation of the cell biomass containing lipids is obtained
PCT/U82012/046696
using centi‘ifiigation, filtration and/01' flocculation or similar ques. in a niefei‘i‘eo
ment, an algal biomass is obtained from a culture using eentrii‘ugation. in a thriller
profound ment, ifiigation occurs after tlte cell culture is cooled ( e. g., to allow
recoveiy of cells containing elevated levels ofllpi-zl). E11 50'13 embodiments an algal biomass
Ui obtained is spray—dried and used (eg, directly used in animal feeds or for biofuel
production).
in one embodiment, the algae is a e of different algae species (e313,, one ot more
of the species ol‘algae described herein). in some embodiments, an algal s containing
ed levels oftotal fat and/or lipids ted from an algal biomass containing elevated
l0 levels of total tatis supplemented Withliipidsto,“ V111tsatuiated fatty acids) 1‘1ont otliei
3, , pol
sources including, but not limited to, plant sources.
in some embodiments, an algal biomass containing elevated levels of total 1‘91:
compiise lipids at a concentiation tw’w)in a tango f1oin about 60-90% (eg about 65-90‘41
about 66—89%, about 67—88%, about 68—87%, about 68—86%, about 69—85%, or about 70
1.5. 0/6} Thus, an lgal biomass containing 6levatedlevels of lipids may comprise lipids ata
concentration ol‘6i8/9,6728/63, 6386. 64"/9,65%, 66% 6/ 9,688%o, 69%, 70%, 7l%, 72%, 73%,
74%, 7584, 76%, 77‘678%,79%,80/6, 81%, 8862, 83%,84 ‘3/6 85/9, 86% 1,88%,89‘36,
90/o antltlme like in one embodiment an algal biomass containing elevcttfiid levels of total fat
comprise lipids at a concentration of at least 67%.
in some embodiments, DHA is included in an algal biomass composition oftlic
invention in a range from 1‘36 to 75% oftotal lipitis’fattv acids. Thus, the DHA can be
provided in the itit’ln in an amount of total fatty aoi-its of £8413, 2‘36, 38/93, ‘ 86,5
- 413 6‘36,
78/63, 8‘36, 9‘36, W89, ll‘36, 3‘341,l ‘36, l5“/63, l6‘34l.,7%, 18%, l9‘341,20‘36, M86, 22%,
23"6, 24%, 2589, 2’‘36, 2 "3/9, 28%, 29%,30‘41, about 3.50 {Hut 409‘/9, about 45%, about
‘36, about 55‘/41 about 60%, about 65%, about 70%, about 7.5//9 and the like. in other
ments, the DllAan be includedin a contposition in an amount ot total latty acidsin
a range from 1% to 5‘36, ‘36 to 10%, % to 15%, 1% 020%, l‘36 to 25%,"36 to 30%, 58/616
“7%, 5% to 15%, 5% to 2 ‘36, 58/9 to 25%,5,.6 to 308/9, l0‘36 to 1589,1096to 20%, 10% to
2.5%, l0‘36 to 30%, l5‘36 to 20%,115°6 to 25%, l5‘3’6 613086, 20% to 25%, 21 8/6 to030%, 25%
(A! .
1 to 30%, 30841 to 35%, 358.41 to 408/, 40% to 45%, 45% to 50% 50‘36 to 5 old.) 600/o,
60% to 65%, 65‘76 to 70%, 70% to 75%, and the like.
in some embodiments, palinitie acid is lnolucled in an algal s composition of
the invention in a 1ange iiom l°39to75,/-11 oi total lipids/titty acids Titus the palniitie acid
can be provided111 the composition in an amount oitotal latty acids oll‘““1,22%. 3%, 4%, 5%,
PCT/U82012/046696
6%, 7’96, 896, 9941, 10‘7'.‘119/11, 12%, 13%, 1491 15%,1113921, 17%, 11196, 19%, 203/11 21%, 22%,
396,249/-. 25941311942102.7941.28%,2991,30922111011135011111111404, about 45/0, about
50%, about 55%, about 00%, about 65%, about out 759/11, and the iike. in other
embodiments, the pain‘iitie acid can be ineinded in a composition in an amount of totai fatty
acids in a range from 19/6.- to 59/6, 1% 10 10% 1% 11; 15%,19/1- to 209/, 1% to 259/11, 96 to 3096,
596 to 109/11, 5.9610 15%, 5% 10 20%, 59/110 23/11, 596 to 31194.1, 109610 1590,10"610 2196, 1096
109/010 309/11. 15% to 20%. 15/111259015/610 31‘296, 209’m 102 20% to 30/6,
% 105096, 309/1110 35%, 359/1110 40%, 40911 to 45%, £15941t0 509/11, 51 9601:5594:, 559610
0096, 609/11 to 05%, 1559/11 to 70%, 70% to 759/21, and the 1i1<1e
Additionai ments of the invention in0-.11110 131000sses 01" making aniinai feed
additives. Thus, one aspect of the t invention is a process of making an 1 feed
additive comprising iinids from an aigae (e.g., an a1ga1 biomass}, the process comprising:
coitivating aigae tn produce a aigae biomass ning a desired, elevated ievei l fat
(0.};, "reater than 0ta1 flat); and extracting a1gee iipid front. the aigae biomass to produce
a 111g;1e (iii; an' 1’0r retrieving 1 'ater from a1gae biomass to produce a ziigae biomass with a
soiids centeni from about 5% to 1009/11 weight percent; wherein the aniniai feed additive
comprises 1ipids 110111 the :11 gee. 111 some einhndintents, the fatty acids coiieeted front the
a1gae are short chain, medium or iong chain omega—3 fatty acids. 111 further embodiments, the
a1gae 1ipi<1 extracted from the a1gae biomass is ed with a aigae biomass with a s01ids
content "rtrem ahc-tit 59/13 to 100% weight porecnt.
A feed additive according to the invention can be combined with other food
components to produce proncss011 food or feed [110(1LL1‘1 (co, 0111111211 and’01 human teed
products}. Such other food components ineiude one or mere enzyme ments, vitamin
food additives and niinerai food ves. The ing (combined) feed additive may be
mixedin an appropriate amount with the other 10011 compo-tents such as cerea1 and p1ant
ns to 101111 a sed food product. Piece ingt1‘ these components into a processed
food product can be performed using any conventionahy used processing apparatuses‘.
Peed/food additives of the present invention maybe used as a suppientent in a hind/feed by
itse1f, in addition with vitamins, minerais, other feed enzymes, agrieuitura1 co—produets (13.51..
'30 wheat middiings or corn gluten meal), or in a combination ith.
111 a further aspect, the invention provides a process 01‘ predncing an aniinai and/01‘
human having an increased tissue content 1211203, fatty acids, the process comprising,
feeding to an anirnai/human a feed additive comprising 1ipids/ta't’ty acids co11ected 110111
aigae, the feed additive further comprising: (a) an aigae 1ipid extracted from a cuitivated
WO 10090 PCT/U82012/046696
algae biomass and/or (is) a algae biomass from a cultivated algae, wherein water is d
from algae biomass to achieve a solids t from about 5 to lOli‘f/o weight percent, wherein
the /human displays increased tissue content {if omega} fatty acids, The invention is
not limited to any particular mammal (ea, animal or human) that may benefit from a
U1 composition of the ion. indeed, animals oldie invention include, but are not limited to,
any animal whose eggs, meat, mills or other products are consumed by humans or other
animals. Tints, animals of the invention include, but are not limited to, fish, poultry
(chickens, s, ducks, eta), pigs, sheep, goats, rabbits, beef and dairy cattle.
in some embodiments, tl e invention provides a method for treating a mammalian
l0 disease in a t in need thereofby administration to the subject a therapeutically effective
amount of a composition of the invention, in some embodiments, a mammalian disease that
is treated includes, but is not limited to, a cardiovascular disease, an inflammatory disease,
and various cancer diseases. In other embodiments, the cardiovascular diseases to be treated
include, lint are not limited to, liypeitriglyeeridemia, coronary heart disease, stroke, acute
lS myocardial infarction and atherosclerosis. in further embodiments, the inflammatory
diseases to be treated e, but are not limited to, asthma, arthritis, allergic rhinitis,
psoriasis, atopic demiatitis, inflammatory bowel diseases, Crohn‘s disease, and allergic
rhinoconjonctitis, in still further embodiments, the cancer diseases to he treated include, but
are not limited to, te cancer, breast cancer and colon cancer. in additional
embodiments, the mammalian diseases to he treated include psychiatric disorders Psychiatric
ers include, but are not limited to, depression, hipolar disorder, schixophrenia. in
addition, the compositions of the invention can be used to maintain and"or enhance cognitive
function.
in some embodiments, the invention provides a method of treating a ian
[\3 L!i disease in a subject in need the eotby administration to the suhj ect a therapeutically effective
amount of a lipid composition provided by and/or obtained from an algal biomass containing
an elevated level l fat (eg, greater than 67% total 1‘ Subjects that may find benefit
from treatment e but are not limited to, avian and mammalian subjects. Mammals of
the present invention include, but are not limited to, canines, felines, bovines, caprines,
(A! ,
, equines, , porcines, rodents (egg. rats and mice}, lagomornhs, es (including, non-
human primates), humans, and the lilie, and mammals in utero. Any mammalian subject in
need of being treated according, to the present invention is suitable, Mammals of the present
invention include, but are not limited to, s, felines, hovines, caprines, equities, ,
es, rodents (eg, rats and mice), lagomorphs, primates (including non—human primates),
is) ~J
PCT/U82012/046696
111111121115; and the like, and s in titero. ing to some embodiments of the present
in *ention, the mammalis a non“human mammal. 111some;=11hodiments, the mammal is a
human subject. M alia11 subjects of both genders and at anv stage 0i development (so
. ,
neonate, infant, juvenile, cent, adult} can he treated according to the present invention.
U1 illustrative aviansaecordingto the present invention e chickens ducks turkeys Reese.
quail, pheasant. raiites leg, tistrich). doinestir;ated birds: eg parrots and eanaiies), and birds
in ovo.
Algae
l 0 Any algas capahls of producing, using the processes bed . elevated levels
oftotal fat or algal biomass containing elevated levels of total fat can he usedin the
processes, e in tositions y supplements hiofuei and/or hiotuel precursor and/or feed
additi es of the invention. Thus. in some embodiments, the algae of the present invention is
selected from litmusoch Wit/1m Difiophvceae {ijvpzopht’ceae zit/6170101011221” ”as,
pingaiophvcsee. and combinations thereof in other embodiments the algae of thein 1,!ntion
are selected from ThrowL.slochvtrzwn strzalzmz, N'meiwocll’IVI‘i/lm Inseam, ioch‘lliitffli
at;cum Cray-1'heeonlz’iziwn coMia Parieloehk?its 1pp Rhodomomts spp Captains: as app
Parietochim‘is spa 1161111512511er sop Pwprzwzdmm shop Glossomastzx spp.. and
combinations thereof. in further embodiments, the algae of the invention are selected from
Pariefochloris impish, onus saline, Hemiselmis bi‘trztrzstrens, P()Ij0lzyridiuln premium
and nmstix clpysopi’asa‘cn and combinations thereof. in still finther embodiments, the
altea tl’il’lfi,lilVLlll"l’l{[12 is Sehz'orhvfrmmimarimim.
in some embodiments of the invention the algae is 3 mixture ol'dilfirent algae
species. in other ments. the algae is a single algae species. in some ments of
the present invention the algae lipids/lam! acids are provided as an algal oil. in other
embodiments, the algae lipids/latty acids are provided as an algal biomass leg, a dried (e.g.,
powdered) hi00111as:9}.
Further, the algae of the invention include. but are not limited to, Wild~type, mutant
ally or induced) or genetically engineered algae. 'n a red embodiment, an algae
used in the processes, compositions, dietary supplements, hiol'uel or blofuel precursor and/"or
eed additives of the invention is a non-genetically modified organism. As used herein. the
terms "genetically modified variant," and ”genetically modified organism'refer to an algae
strain that has a genome whichis modified (e from its normal (e.g
. mutated Changed) .
wild-ty e, naturally ing) form such that a desired result is achieved.
PCT/U82012/046696
Additionally, the algae of the invention includes algae having cells with cell walls of
reduced thickness: as: ed to the cells ol‘wild-tyne algae, whereby the cell wall cf
reduced thickness improves extractability and/or hioa‘y'ailahility of the algae lipid fraction
(egg, ing the ease of (ll Vestihillty of the algae and the ease of extractahility cf the algae(3»
U1 lipids/fatty acids from the cells of the algal hlun’lassl. Algae having cells with cell walls cl“
reduced thickness as retl to the cells of wild-type algae can be lly occurring,
mutated and/or genetically engineered to have cell walls of reduced thickness as ed to
wild~type strains. Thus, in one embodiment of the invention the algae is an algae having a
cell wall of reduced thickness as compared to the Wild-type algae, whereby the cell wall of
l0 reduced thickness improves tabiliw and/or hioavailahility of the algae lipid fraction,
Methods of producing algae with reduced cell walls include those found in W 2006/1 07736
Al, herein incorporated by reference in its entirety. Thus, the algae can he mutagenized with
nrutagens knewrt tn those of skill in the art ing, but net limited tn, chemical agents er
radiation, In particular embodiments the chemical mutagens e, but are not limited to,
l5 ethyl rnethanesulf nate (EMS), tnethylrnethane sult‘onate (HMS), N—ethyl—N—rntrosourea
(ENU), triethylrnelarnine (TEM), N-—nretl1yl-—N-—nitrusourea (MNU), prucarhazine,
chloramhucil, hosphartridc, l e, actylamide monomer, rnelphalan, nitrogen
mustard, Vincristine, (llmethylnitrosamine, N—methyl—Nl—nitro~Nitmsoguanldine (MNN Cs),
rtitrosoguanidine, E—aminopurine, 7,l2 dinrethyl~henz(a)anthracene (DMBA), ethylene oxide,
{.40 hexamcthylphosphoramidc, hisult‘an, diepnxyallranes (tjlicpnxyoctane (DEG), dicpuxyhutanc
(BBB), and the like), 2—mothoxy—6—chlcro—QQB—(ethyl—Z—chlcr~o~
cthfiaantinnpropylaminrfiacridinc rochloridc (lCR— 70:)“ thrntaltlchy dc, and the like.
Methods of radiation mutagenesis include, but are not limited to, Xurays, gamma-radiation,
ultra—Violet light, and the like.
Cell wall mutants can he selected for on the basis of increased sensitivity to detergents
01‘ by microscopic observation of tions in cell wall thickness (See, e. 9;, WC
2006/? 07.736 Al) or any other method known in the art tn detect reduced cell wall thickness
or reduced cell wall integrity.
The algae of the invention can he cultured according to techniques described in
'30 Examples l—3.
Accordingly in some embodiments the algae are cultured at a, temperature in a range
from lOGC to 3500 Thus, the algae can he cultured at a temperature uf l 00C, lloC, 12°C,
130C, l40C, lSOC, lt.°C, l70C, lSDC, l9°C, 200C, 210C, 220C. 230C, 240C, 250C, 26°C., 270C,
2804:, 29°C, 300C, 31%; 32°C, SST, 340C, and the like. In other embodiments, the algae can
PCT/U82012/046696
be grown in 1213-gesh'ont 20°C to 35°C, although colder (eg, less than 20°C) and warmer
eg more that
, ) may be used lo a preteried embodiment, the algae are grown at about
300C.
in some embodiments, following cultivation, algae ale liatVested in some
Ui embodiments, harvesting of algae is performed using, conventional procedures lillt’lwn to
those of shill in the art including, but not, limited to, cenlril‘ugaticn, flocculation or filtration.
in a preferred embodiment, prior to harvesting, the algae re is cooled, theiehva‘ ig
algal cells containing elevated levels oftolal fat to he successliilly harvested. The harvested
algal cells or algal biomass can then be used directly as a lipid/fatty acid source or extrac ‘eil
l0 to obtain algal oil 130-nprising thehipidS,’fatty acids in some embodimentsin which the algal
biomass is to he used directly, water is removed from the algal biomass to achieve a solids
content from about 5 to l00 weight percent. In additional embodiments, an algal hiemass
that is to he used directly is sed of algal cells further comprising cell walls that are at
least partially disrupted to se the extraotabilitj anti/or hioavailahility of the algal oil
l5 within the cells. The disruption et‘the algal cells can he carried out aceerdlng te knewn
techniques ing, but not limited to, treating the cells with boiling water or by mechanical
breaking such 5 s grinding, pulveriziiig, tion, French press, or any other method known
to an ordinary artisan,
When the algal biomass is used directly. water is ved from the algal biomass to
achieve a solids content from about 5 to “30%, Accordingly, in seine embodiments, water is
removed from the algal hiontass to achieve a solids content of about 50/95, l09‘6, l5%, "20%,
2595,3594, «95,4995.4594., 51395, 55 5.50.94. 5:595, 595 5794. 5595,5597 7574. 7195, 7295.
73955494575,595 5,77%, 759,5 799555934,;5195, 5295,:53°4.,54955595,55°4:.,.795,88%,
89%, 90%, 9l%, 92%, 93%, 9495,,5%,3595, 97%, 98%, 99%, l00%, and the like. in
[\3 L!i onal enthodiments, water is removed from the algal biomass to achieve a solids content
in the 1ange l1out about 5% to 509’s, 5'70 it; {3095, 59/3) to 70%59’s to E909/5, 590 to 90%, 5% to
95%, 1096th 5094', l-’9’5 to 40%, 109’40 to 509t), l0':‘4'5 to 60% l004'th {35%, l04’oln '09E), l0'4’5 lo
75. ,109(Mo 80%, l)% to 85%,10% to 90%, l09’6 to 95%, l09'45 to 10“/o,l 95 to 40%,l 5%
to 5095,l 5% to 60%,l 5%tto (15%, iii/5 to 709/15, l59’(3 t175%, l5% to 80%, l59€> to 85%,
(A! ,
9 lilo/i) l0 900/8, isll/h EC 9597), l57/h it) l00%, 207/6 l0 50°75 0 60%- 657/5, 20%) it)
70%), 20°47 10 75°46, 20°43 10 80Al, 20°43 l0 85°13, 200’0 l0 Ell/9’'13, 209(ill) 95°’,2 9?) 10 “90943, 25°46
€03900’, 25//0 it) 60%;, 25/0 it) 70°40, 25//'0 £0 75 9;), 25%) it”; 80%,25°’o 10 85°/'o,A250/0, 10 90°14),
°43 10 93°45 3590 it) 100%, )00’'1) l0 50°43. 30961( it) 60943, 3092’) l0 7‘l%300/0 [0 75°40, 309/5 l0
809/1'1,30°’to 35% 304’ to 90%, 3045143 59,2) 45‘44'5 lo l0l96, 5092; to 70%, 50% to 75%, 509/5
51.4 ”“551
PCT/U82012/046696
£0 80%, 50‘36 to 85%, 50941 «190%, 50/‘3, to 95'36 51336 to l00'36 55‘361’0 ”5‘36, 55% to 8ti3‘36,
55‘36m 85%c, 55‘36 to 90%,553610 95%, 553610 30036 600/: to 75‘3‘6 6004:.» to 803o 60% to
8, ‘36, 60% to 9‘36,60”/0 to 95% 60% to 3000'm 70% to 80“Al. 70% to 85% I 3‘36 to 90%, 70%
to 95%, 70% to 100%, 75 6to85°.6, 75% lo 90%, 7.596111 95%,” 5% to l00‘36, 80% 115.85 ‘36,
809-6 to 9096., 80% to 95%, 80"6 to 1009/: 8596 to 9i3061,8596 to 95%, 85% to ltll’l‘i/o, 90%. to
95%, 95% to H3096, and the like.
in some embodiments the alsralcells ot t11e biomass are disrupted or lysed and the
algal lipids extracted. The algal cells can be extracted wet or dry according to tional
techniques to produce a composition ning lipids/iatty acids. The disruption or lysis of
l0 the alcal cells or-n he carried out atcording, to conventional techniques including, but not
limited to, treating the cells with boiling water or by mechanical breaking such as grinding,
pulverizing, sonication, French press, or any other known method. Extraction of the
lipids/latty acids from the lysed cells follow standard procedures used with algal and other
sms that are known including, but not limited to, separating the liquid phase from the
l5 solid phase 'olllowingcell lysis,ext1acting the lipids,I’fatty acids in the liquid phase by the
addition of a solvent evapmating the solvent, and recovt.ring the lipids/fatty acids obtained
from the liquid phase of the lysed cells.
”'lheinvention is not d to any particular SUlVL>1t med for extraction. Solvents
include, but are not limited to, hexane, chloroform, ethanol, methanol, isopropanol, diethyl
{.0 ether, (lies an, isopropyl ether, tilichloronicthane, ydrotiiran, eum ether and
combinations thereof
in some embodiments, lipids/"fatty acids derived from an algal biomass oi‘thc
invention are provided in the form of free fatty acids, cholesterol esters, salt esters, fatty acid
esters, nionoglycerides, erides, triglycerides, diacylglycerols, ycerols,
sphin{ophosphcl:pids, splnnaovlvcoipids, 01 any ation thire11t(e,1“11r use in
ses, compositions, hiolnels, oducts, dietary supplements, teed additives 151 othe
compositions described herein).
Method tor Preparing An Algaltl Biomass
'30 in some embodiments, the invention provides a method for preparing a algal biomass
comprising elevated levels oi total fat (e.g greater than 67'36 lipidsl comprising: culturino
algae under a culture condition sufficient to provide an algal biomass comprising elevated
levels of total fat (cg, r than 67% lipids), wherein the algal s is harvested at the
termination ofa logarithmic growth phase oftl e algae (See,e.gE11aniples l and 2). As
v.2 1,.“
PCT/U82012/046696
used herein, the term "logarithmic growth phase," refers to a stage of culturing characterized
by exponentially increasing s ofalgal cells. ‘enerally, in a culture system, there is a
characteristic growth pattern following ation that includes a lag phase, an exponential
or "logarithmic growth phase," a negative growth acceleration phase, and a plateau or
U1 "stationary phase.” For example, in the logarithmic growth phases as growth of the algae
continues, cells can reach their maximum rate ol‘cell division and numbers of cells increase
in log onship to time. Within time after the commencement of the log phase, the rate of
cell division may begin to e and some of the cells can begin to die. This is rellected on
a growth curve by a gradual flattening out of the line. Eventually the rate ol‘cells dying is
l 0 essentially equal to the rate of cells dividing and the total Viable population can remain the
same for a period of time, This is known as the stationary or plateau phase and is represented
on a growth curve as a ning out ol‘the line where the slope approaches zero. in a
preferred embodiment, the algal biomass is cultured under aseptic conditions (eg, to prevent
contamination and/or growth of contaminating microorganisms (cg, yeast, bacteria,” VlFUSl
etc.) in the culture).
In some embodiments, the culture condition is sutlicient for the algae to produce
elevated levels- of total fat (egg, greater than 67% on a w/w basis), The culture conditions
comprise a culture medium suitable for g the algae thereby providing the algae
biomass comprising elevated levels of total fat tag greater than 67% on a w/‘w basis}
Suitable culture mediums are bed herein. The medium may also comprise salts,
Vitamins, mincralm metals, and other nutrients. Preferably, the culture condition is sufficient,
to provide a suitahlc amount rient and ature for the algae to grow under
conditions that: generate an algal biomass comprising elevated levels of total fat.
ln some embodiments, culturing comprises limiting a nutrient leg, nitrogen,
L! phosphorous) for a suitable time to increase the amount total fat. For example, the culture
can be starved of a certain nutrient or transferred to a separate culturing medium lacking a
specific nutrient (cg, phosphorus—tree or nitrogen-lice medium, or a culture medium
containing lower levels of a nt). in some embodiments, the culture medium contains an
initial content of a nutrient such that that nutrient s depleted at a later time during
(,2 exponential growth but prior to the ion of other nutrients. in some ments,
culturing does not comprise limiting a nutrient ife.g, nitrogen, phosphorous) during culture.
ln some embodiments, culturing of a single algal biomass takes place in two or more types of
medium in a sequential manner. in some embodiments, culturing of a single algal biomass
talres place in three or more types of medium in a sequen manner. in like manne
~14 {x}
WO 10090 PCT/U82012/046696
ing of a single algal biomass may take place in two or more vessels, wherein a first
vessel is used to ate a subsequent vessel, the subsequent vessel is used to lnoeolare yet
another subsequent vessel, and so 011. Although an understanding ol’a ism is not
needed to practice the it ventiott, and the invention is not limited to any particular mechanism
Ui ol‘action, in some embodiments” sequential culturing of a single algal biomass in multiple
vessels containing multiple types ol‘medium allows the algal biomass to grow in such a way
that the total fat content of the biomass is elevated eotrtuared to growth of an algal biomass
(e.g., of the same algal species) grown in a single vessel ‘ ltd/or growth medium.
Culturing of the algae can be performed in a conventional loioreactor suitable for
l0 culturing the algae to provide an algae biomass] For example the algae can be cultured by a
process ing, but not limited to, batch, fed~batch, cell recycle, and continuous
fermentation. in a preferred embodiment, the algae are cultured in a t”erl»»bateh process.
The invention is not limited to any particular manner or method of ting the
algae from the culture medium. A variety of methods can he used to harvest the algal cells
l5 hunt the culture . in one embodiment, harvesting comprises recovering the algal
biomass front the culture medium by separating, for example by filtration (ego belt filtration,
rotary oltnni filtration;t and/or centrifugation. if desired, the harvested algal cells can then be
washed, frozen, lyophilizerl, spray dried, and/or stored under a non—oxidizing atmosphere of a
gas (e.g., (70;, N2) to reduce or ate the presence of 03. ally, synthetic and/or
natural antioxidants including but not limited to, h’otylatcrl hydroxytolnenc (Bill), butylatcrl
hydroxyanisole (BRA) tett—hutylhydroquinorte (lBHQ) ethoxyquin, beta~earotcne, vitamin
E, and vitamin C also can be added to the hart‘ested cells.
In some enihotilirnents, the ion provides a method for ing an algal
biomass comprising elevated levels of total fat, the method comprising: culturing algae under
[\3 Ln a culture condition sufficient to e an algal biomass comprising elevated levels of total
fat and l‘larvestlng the algal biomass.
Microalgae s
The invention provides, in some embodiments, an algal biomass and/or a fraction
(A! l
, and/or an extract thereof (eg for use in bioluel production and/or as a food or feed t).
in some embodiments, the algal hion‘rass comprises: an omega-3 fatty acid content of
at least lOO/b (lay weight of the biomass, illustt‘atively, about lilo/h to about 50%, about lllli/o, to
about 40%7 about l0% to about 30%. about llli/tt to about 26% dry weight of the biomass. In
one enrhodimenh the algal biomass is prepared in accordar ce with the methods oftl e
11.2 (a)
PCT/U82012/046696
invention. For example, in some embodiments, the algal biomass is prepared by a method
comprising: culturii ' an algae under a culture condition sutiicient to provide a algal biomass
comprising elevated total fat levels (cg, greater than 67% w/w‘}, wherein the algal biomass is
harvested at a negative growth acceleration phase or a stationary phase, in another
U1 embodiment, the algal biomass is harvested from the culture during the exponential,
logarithmic growth phase.
Lipid Compositions Prepared From Algal Biomass
in some embodiments, tl e invention provides a method for preparing a lipid/fatty acid
l 0 t leg” a lipid/fatty acid composition) from an algal biomass grown under conditions to
contain elevated levels of total fat, the method sing obtaining lipids from an algal
biomass cultured under a culture condition sufficient to e an algal biomass with
elevated total fat content (e.g., total fat content greater than 6.7% of the s), wherein the
trial biomass is harvested at a ve growth acceleration phase or a stationary phase of the
algae. in another embodiment, the algal biomass is harvested during a logarithmic growth
phase of the algae.
Methods for obtaining a lipid composition from an algal biomass of the invention
include, but are not limited to, extraction, heat, pressure, saponification, tion, freezing,
grinding, ion ge, chromatography, membrane separation, electrodialysis, reverse
osmosis, distillatirm, chemical dcrivatization, lliaation, etc, For example, algal lipids
can be extracted from the algal cells by any suitable method including, but not limited to,
extraction with a solvent ing, but not limited to, ethanol, ethyl acetate, isopropyl
alcohol: methanol, ethyl acetate, hexane, ene chloride, methanol, petroleum,
chloroform, and the like, or by pressurized liquid hydrocarbons such as butane, pentane,
L! propane, or others (with our Without (Jo-solvents), or through supercritical fluid extraction
(with or without (so—solvents). Optionally, the ted lipid/tatty acid oil are evaporated
under reduced pressure to reduce or remove the solvent anchor produce a sample of
concentrated lipid material, in. other embodiments, the cells are broken or lysed to obtain the
lipid composition, for example into an oil form leg, for use as a hiofitel or a biofnel
(,2 sor). in some embodiments, the extracted oils are subjected to g. The invention
is not limited by the type ol‘rel’ining. In some embodiments, the extracted oils are chemically
d. in some embodiments, the extracted oils are physically refined. in some
ments, the extracted oils are both chemically and ally refined. Extracted oils
(ego from an algal biomass grown under conditions to ele’r ate the total fat content of the
11.2 .4}.
PCT/U82012/046696
algal cell (6.9;, to above (Wt/bl) may be refined using any conventional refining method. ”hie
‘etining process may remove some or all impurities from hc- extracted lipids/fatty acids/oils.
ln some embodiments, the refining process comprises one or more steps to degum, bleach,
filter, deodorize and/or polish the extracted lipids/fatty acids/oils.
U1 in some embodiments, the /Fatty oils contained in the extracted lipid
composition is concentrated by hydrolyzing the lipids to concentrate the lipid fraction by
employing a method such as, for example, urea. ction, fractional distillation, column
tography, and/or supercritical fluid fractionation.
Accordingly, in one embodiment, the s ‘ep of ing a lipid composition from an
l 0 algal biomass of the invention. comprises extracting the lipid composition from the biomass.
ln another embodiment, the step of obtaining a lipid composition from an algal biomass of
the invention comprises contacting the biomass with a polar solvent.
For example, in some embodiments, lipid/fatty acid/oil is extracted from the algal
biomass to provide a lipid composition using a solvent under an extraction condition
sufficient to extract lipids and/or fatty acids but not sufficient to extract compounds that are
insoluble in the solvent. in one embodiment, a lipid/fatty acid composition is extracted from
an algal biomass of the ion wherein cellular debris and/or precipitated insoluble
compounds are separated from the fraction containing lipid/fatty acid and solvent. in another
embodiment, the method further comprises separating the cellular debris and precipitated
compounds using a separation method such as filtration, ccntrithgation, and/or cotrtbinatiirms
thereof. ln some embodiments, the cellular debris and"or precipitated ble nds
(cg, that portion 0-9 the algal biomass that are not soluble in a solvent (n.3,, proteins, tibcr,
etc) are recovered and utilized tag, in a food or teed product).
in some embodiments, the solvent is a. polar t. es ofpolar solvents
L! include, but are not limited to, ethanol, ethyl acetate, isopropyl l, methanol, ethyl
acetate, and mixtures thereof. in one embodiment, the polar solvent is ethanol. Extraction of
the lipid composition with a solvent can be carried out in a variety of ways. For example, the
extraction can he a batch process, a continuous s, or a continuous counter-current
s. lo a continuous coroner-current process, the solvent contact with the microalgae
(,2 leaches the oil into the solvent, providing an increasingly more solvent-oil traction.
Following extraction, the solvent can be d using methods ltnowri in the art. For
example, lation, rotary evaporation, or a rising film evaporator and steam stripper or any
suitable entizer can be used for removing the solvent.
in one embodiment, the extracted /fatty acids are d to an absorption
11.2 Lil
PCT/U82012/046696
process (e.g., bleaching) to remove one or more undesirable compomids such as for example,
color bodies and/or ohosohaticlcs that may be present, in some embodiments, the absorption
process is a bleaching process comprising contacting the spin/em acid extract with a
bleaching, material tag neutral earth (eg, natural clay or ‘s , ctivated earth,
Ui activated car ion, activated clays, silicates, and or a combination thereof}, The ion is
not limited by the amount of bleaching material utilized.
in one embodiment, the extracted lipids/Fatty acids are exposed to a degunnning step.
Degumrning methods are ltnown in the art and include, for example, water degumming, acid
degumniing, enzynr tic degumming, and membrane degornming. in some ments, ti c
it) lipid/fatty acid extract is suhj ected to deguinniing (cg following an. absorption process),
wherein the degumnring comprises contacting the lipid/fatty acid extract with a mixture of
aqueous acids that are in amounts ei‘iective to precipitate gums and/or chlorophylltype
compounds that may he present in the lipid/fatty acid extract ition. The invention is
not limited by the type or amount of aqueous acids utilized. in one embodiment, the mixture
iii of aqueous acids ses sulfuric acid and/or phosphoric acid. in another embodiment,
equal amounts of aqueous acids are mixed with the lipid composition. in a preferred
embodiment, when d with the oil, the aqueous acids are in an amount sufficient to
provide an acidic pH, Precipitates that form after acid mixing can he removed from the lipid
composition, for example using centrifugation and/or filtration tag, membrane filtration). in
some embodiments, the dcgnmmcd lipid/fatty acid extract cmnposition is subjected to drying
(eg, to reduce moisture content of the composition}. The invention is not d hy the
drying condition (cg. tirnc, temperature, and/or a vacuum condition). As described herein,
in some embodiments, the moisture content of the dried lipid/fatty acid composition is less
than about it)% W/W (cg. less than about 9, S 7, o 5, 4, 3, 2 l, n.9, 0.8, 9.7, (it), 0.5, (ix-l,
0.3, (3.2, til, 0.05, or GOP/23 w/w).
Lipid ition
in some embodiments, the invention provides a lipid ition prepared from a.
algal biomass of the invention. in some embodiments, the lipid composition is prepared in
'30 accordance with a method of the invention. For example, in some embodiments, a lipid
composition is an algal s or a portion/fraction thereof from algae of the genus
Titan:mtochytrimn. in some embodiments, the algal biomass comprises an algae selected
from izyceoe, tophyceaa Trebouxiophyceoe, Pinguz'opizyceue, and/or combinations
thereof. in other embodin ents, the algal biomass comprises an algae selected from
11.2 v“,
PCT/U82012/046696
Thornton/"ztritium slriuiu‘m. T/zmLts‘toc/zvtrizmz mt, tsSoc/:vzrium azurazmz
~ , J , .) 7
Crvnthewa‘intum comm Parietocleoris 31a Randi-Jammy rm, Cr ultimcmus Sf} J,
1 3 7
. f I l l 7
,Parietocl’zloris Sim” Hartline/brats 5 J,’ POI‘Ji'Z Widow: Sim, (flossomaslit S and/or
, f” a :3. , 11 r
combinations thereof in further embodiments, the algal biomass comprises an algae selectet
U1 from Parietochiom' incite, Ritmz’omwuw saline, Hazardous firzmescens, Porphw‘idimn
tinge/item and Glossomuslix chijto‘twlusla, and ations thereof, In a preferred
embodiment. the algal biomass comprises Schizacitvtriwn liraacz’mmi.
Food Products and Animal Feed Additive ‘
l 0 in some embodiments, a Whole—cell algal biomass, fraction, and/or extract thereoiC is
used for ption (egg by a mammal (eg, human or animal consumptiunfi or as a food
ve leg, to increase the lipid content and/or nutritional components of a food). For
example, in some embodiments, when used as animal feed (eg, cattle feed, dairy feed,
aquaculture feed, poultry feed, etc), the lipids/fate; acids produced by an algal biomass of the
invention is incorporated into a food product (tag, animal feed), in some embodiments, a
whole—cell algal biomass, fraction, and/or extract thereof is used for pharmaceutical or
nutritional purposes and/or industrial ations,
The whole—cell algal biomass, on, and/or t thereof can be provided in any
one of variety ot‘fortns/conipositions suitable for a particular application or use. ln some
embodiments, the whole-cc l algal s, traction, and/or t thereof is provided. in
another embodiment, a whole—cell algal biomass, fraction, and/or extract thereof is provided
in a powdered form or as a tree oil in a liquid form (eg lipid composition or a fraction or
concentrate thereoi}. A cell algal biomass, fraction, and/or extract thereof may be
used for human and/or animal consumption. For example, in some embodiments, a Whole—
L! cell algal biomass, fraction, and/or extract thereof is provided as or incorporated into a, feed, a
dietary supplement, a food, a pharmaceutical formulation, a dairy product, and/or an infant
For example, in one embodiment, a Whole—cell algal biomass, fraction, and/or extract
thereof is dried (are, spray drying, tunnel , vacuum drying) and used as a feed or food
(,2 supplement for any animal or aquaculture organism (e.g., fish, shrimp, crab, lobster, etc.)
whose meat and/or products are consumed by humans or animals (eg. pets, livestock). in
another embodiment, a whole—cell algal biomass, fraction, and/or extract thereof is mixed
with a dry moisture~reducing agent leg, ground grain such as ground corn).
The compositions described herein may be used as a complete food product, as a
11.2 ~J
2012/046696
component of a food product, as a dietary supplement or as part of a dietary supplement, as a
”cred additive and may be either in liquid, semisolid or solid form. The compositions of the
ion additionally maybe in the form oi‘a ceutical ition. The
compositions, dietary supplements, food products, baby food products, feed additives, and/or
U1 pharmaceutical compositions of the invention may he uti. ...ed in methods for promoting the
health of an individual. The compositions may be in liquid, semisolid or solid form. For
example the compositions may be administered as tablets, gel packs, capsules, gelatin
capsules, flavored drinks, as a powder that can he reconstituted into such a drink, coolting oil,
salad oil or dressing, sauce, syrup, mayonnaise, ine or the like. Furthermore, the food
l 0 product, dietary supplements, and the like of the present invention can include, but. are not
limited to, dairy products, baby food, baby formula, beverages, bars, a powder, a food
topping, a drink; a cereal, an ice cream, a candy, a snack mix, a haired food product and a
fried "cod product. Beverages of the invention include hut are not limited to energy drinks,
nutraceutical drinlts, smoothies, sports , orange ju’ce and other fruit drinks, A har of
the present invention includes, but is not limited to, a meal replacement, a nutritional bar, a
snaclr har and an energy bar, an extruded bar, and the like. Dairy products of the ion
include hut are not limited to, including hut not limited to yogurt, yogurt drinks, cheese and
millt. Compositions intended for oral administration may he prepared according to any
known method for the manutacture of dietary supplements or pharmaceutical preparations,
and such compositions may include at least one additive selected from the group consisting of
taste improving substances, such as sweetening agents or tlavoring agents, stabilizers,
emulsifiers, ng agents and preserving agents in order to provide a dietetieally or
phartnaeeutically palatable preparation, Vitamins? minerals and trace element from any
physiologically acceptable source may also be included in the ition of the invention.
L! in some embodiments, a pharmaceutical composition ofthe invention comprises the
compositions of the invention in a eutically effective amount. The compositions of the
invention can be formulated for administration in accordance with ltnown pharmaey
techniques. See, e.g., Remington, The Science And Practice of Pharmacy (9th Ed. 1995‘}. in
the cture of a pharmaceutical composition according to the invention, the lipid
(,2 compositions {including the physiologically acceptable salts thereof) is lly admixed
with, inter alia, an acceptable carrier. The carrier will be ible with any other
ients in the fornnilation and must not he deleterious to the subject.
Biohtel
PCT/U82012/046696
Many of the existing teclniologies for making hiot‘oel from algae are expensive,
inell‘icient and unsustainable when operated at a scale that is required to ce any
meaningful fraction ot‘petrodiesel in the market The supply and expenditure of energy to
harvest and process algae are often underestimated. To produce biodlesel from algae
U1 conventionally, the algae are typically harvested from a culture at a concentration ofahout
9.2 g/L in water. The harvested algae are then dewalered which increases the algal
concentration to form an algal paste of about 35% solids, The paste is then fully dried by
evaporating the water. Oil is then extracted from the dried algae with an organic solvent.
such as hexane, which is removed by distillation from the algal oil. This conventional
l 0 method for generating sel from algae is prohibitively expensive.
For example, when algae grows in a natural body of water, the algal biomass is
relatively dilute considering the volume of water. ing a gallon of oil requires
processing ol‘about 20,000 to 40,000 gallons of water. The energy cost of transporting and
processing such a large volume of water is high. As example, 2500 gallons of oil/'acre/year
could be produ red it algae with 25% of its mass as lipids could be produced at 25
pQ/day. For this example, 50 million gallons of water must be processed to produce
m»he 2,500 gallons of oil. The rd approach of pumping water to a centralized facility for
ring is simply too -intensive and cost prohibitive, As example, a vely
small algal oil facility that produced 20 million gal/year would expend more energy pumping
water from the pond to a central facility than that oontaincrl in the oil product, resulting in a
not negative energy balance.
Accordingly, in some embodiments, the invention provides a method for preparing an
algal biomass and/or lipid/fatty acid extract (egg a lipid/fatty acid composition) from an
algal biomass, grown under conditions to contain elevated levels of total fat, the method
L! comprising obtaining lipids from an algal hiomass ed under a culture condition
sufficient to provide an algal biomass with elevated total fat t (eg, total fat content
greater than (37"% of the biomass), wherein the algal s is harvested at a negative growth
acceleration phase or a stationary phase of the algae. in another embodiment, the algal
biomass is harvested during a logarithmic growth phase of the algae. Methods for obtaining a
(,2 lipid composition from an algal biomass of the invention are described herein.
Accordingly, in some embodiments” the invention provides a biol‘uel feedstock or a
hioliiel compliant: lipids, arbons, or both, derived front an algal culture and/or algal
biomass generated according to the s of the invention. in some embodiments, lipids
or algal compositions comprising the same are subdivided according to polarity: neutral lipids
L9~14
PCT/U82012/046696
and polar lipids. The major neutral lipids are triglycerides and free saturated and rated
fatty acids. The major polar lipids are acyl lipids, such as glycolipids and phospholinids. is
some embodiments, a composition comprising lipids and hydrocarbons of the invention is
described and distinguished by the types and relative amounts of fatty acids antifor
U1 hydrocarbons present in the ition. in sortie en’ibtniitnents, the hydrocarbons present in
algae compositions of the ion are mostly straight chain allianes and alltenesi and may
include parafi' ‘ and the like having up to 36 carbon atoms
in some ments. the invention provides a method ol‘rnaking a liquid fuel that
comprise processing lipids derived from an algal cul ire and/or algal biomass or lipid fraction
l 0 thereof described herein. Products of the ion made by the processing algal derived
biofuel ocks can be incorporated or used in a variety of liquid fuels including but not
limited to, diesel, biodiesel, kerosene, jetluel, gasoline, J?» l, 394,, IFS, lPo, ill-7, 3P8, let
l’i‘opellant lly Stable (JPTS), Fischer—Tropsch liquids, alcohol-based fuels including
l—containing transportation fuels, other biomassvhased liquid fuels including cellulosic
biomass—based transportation fuels.
in some embodiments, triacylglycerides in algal oil is ted to fatty acid methyl
esters (FAME or biodiesel), for example by using a hasev-eatalyzed transesteritication
process (for an oyen'iew see, egg.s K. Shame "l‘yson, Joseph Bozellg Robert e, Eugene
Petersen, and Luc Moens, ”Biomass Oil Analysis: Research Needs and Recommendations,
NRElJ/TP-S til-347%, lune 200% hereby ratcd hy rcl‘erencc in its entirety) to some
embodiments, the triacylglycerides are d with methanol in the ce of NaOll at {it}
C. for 2 hrs to generate a fatty acid methyl ester (biodicscl) and glycerol. in thither
cmbodimenta the biodiesel and glycerol couproduets are ible and typically separated
downstream through decanting or centrifugation, followed by washing and purification. Free
L! fatty acids (lets) are a natural hydrolysis product of triglyceride and fanned by reacting
triacylglycerides and water. in some embodiments, methods of the invention further
comprise a step for quickly and substantially drying the lgal oil by techniques known in the
art to limit production ofl‘ree tatty acids, preferably to less than l‘l/i». in another embodiment
of the invention, the methods can further comprise a step for converting or removing the free
(,2 fatty acids by techniques ltnown in the art.
in some embodiments triacylglycerides in algal oil is converted to fatty acid methyl
esters (FAR/EVE or biorliesel} by acid—catalyzed transesterilication, enzyme—catalyzed
sterilication, or supercritical methanol transesterilication. Supercritical methanol
transes erilication does not require a catalyst (See, e.g., Kustiianai l). and Saka, S.., ”El‘lects of
PCT/U82012/046696
water on hiodiesel fuel production by supereritieal methane-l treatment," Bieresource
Technology 9l (2004), 289-295; Kusdiana, D. and Saka, 8., ”Kinetics oftransesterifieation in
rapeeeed nil tn hiediesel fuel as treated in supereritieal methanol,” Fuel 80 (200] ), 6934398;
Saha, 5., and Kusdiana, 13., "Biediesel fuel from rapeseed oil as. prepared in supercritical
Ui rrretlranel.,H Fuel 8t} ), 225—23 l). The reaction in supereritieal methanel reduces, the
reaction time from 2 hrs to 5 nrinuten. In addition, the absence {if the base catalyst NaOi—l
greatly fies the downstream purification, reduces raw material cost and eliminates the
problem with snaps from free fatty acids. Rather than being a rm the free fatty acids
become valuable feedsteeh’e that are cenverted te- hiediesel in the supereritical methanol as
it) follows.
In sum: embedimentsa triacylglycerides are reduced with hydrogen to preduce
parattins, prnpane, carbon dioxide and water, a prednct lly known as green . The
parat‘tins can either be lsonterized to produce diesel or blended directly with diesel. in some
ernhedintents, there are ages of hydrogenation over ccnvettticnal hase—eatalgzed
lS transesterificalien. For example, the hydrogenatien s (else referred to as
racking) is thermochemical and therefore much more robust to teed ties as
compared to biechernical processes (eg hytlrecraclx'ing is vely insensitive to free fatty
acids and water). Free fatty acids are readily converted to par‘aftirts, and water simply
reduces the l thermal efficiency of the preeess but does not significantly alter the
chemistry in annthcr hen-limiting example, the paraffin prerluct is a pure hydrocarbon, and
therefore indistinguishable from pettnlcum—hascd hydrecarhene. Unlike hiutliesel which has 3
l5% lewer energy content and can freeze in cold r, green diesel has similar energy
content and flew characteristics (eg, Viscosity) te petrnleum—hased diesel. In various
embodiments? the ds of the inventinn encnmpass the steps of hydrocracking and
[\3 L!i isomeriza‘tien, which are we l known in the art to produce liquid fuels, such as jet~fuel, tiieSel,
kerosene, gasoline; ill-l, J94, MKS, ill-ti, JFK}, .lP~8., and JPTS.
EXPERlMENTAL
The following examples are provided in order to demonstrate and further illustrate
(A! t
, certain pretErred emhndiments and aspects of the present inventinn and are net tn he
censtrued as limiting the scape thereef.
Grewth at" high fat. algal hiemasa
PCT/U82012/046696
Experiments were conducted during development ofetrtbodimehts ot‘t’he invention in
order to characterize and estabhsh methods for heterotrophie algae production, and in
particular, s ofeuiturihg algae in order to generate an algal s containing high
fat/1ipid ieveis. A series of conventional trophie atgac production studies was
Ui performed and run batch.
A cuiture ofSchizochylrium rttm; was obtained and stored in 15an eryoviais at
~80 C. For each experimentg the process was started by thawing eryoviais and aseptieatiy
adding to 1.0L shake flasks of with media. Media in the 1 L flasks contained ’50 g/L sugar;
g/L yeast extract, and 4 g/L sea satt. Three liters of 3 to 6 day old shake flash culture was
i0 used to inocuiate a 250 L vessei containing media, grown for 2448 hoarse and then
transferred to a main vessei (17,000 to 2t 3001:.) and run as a batch process for '36 to 72
hours. The temperature of the hatch runs was kept between 25 and 30 C. The temperature
range was large due to lack ofpreeise control of the system. The media used in the seed
(25011) and hater: r, 1000 to 283001;)t.» runs was as foliows:
Table A. Media used in traditionat hatch and seed euitures.
Total fat t of the algal biomass of the hatch euttures was determined by gas
tography (See ADA’C gravimetrie method 92206), acid hydrotysis (See Totai Fat by
Aei d i-iydroiysis Atikoni Technology Method 1, 02—10—09), and High Temperature Solvent
Extraction (See Atrhom Technology Method 2, 01—30—09 and ADCS Method 5-04). In brief,
a t analysis procedure for tation broth was as follows: Broth samples were
concentrated by eeotrifiigatiort, Atter decanting the sample was :tireeze dried for 24- hours
with resuitant moisture iess than one percent. The samples were weighed prior to acid
hydrolysis, washed and dried in an overt. This was followed by an extraction process under
PCT/U82012/046696
gradient thermal conditions with petroleum ether. The hydrolysis and extraction process were
undertaken utilizing automated instruments. After further drying, results were detennined on
the basis ofnrass lose.
As shown in Table lB below, the total late/lipid levels (iv/w} achieved in the hatch
productions at a tern Jerature range from 23-30 C was 23-38%.
'l'able l8. Total fat content of algal s grown in batch run between 25—30 C.
Efforts were made to increase the amounts offal/lipid levels as these s were
considered too low to he of value and additional experiments were run in an effort to increase
the level of lipids produced in cultured algae.
During development of embodiments of the inven'ion, experirtients were conducted in
order to determine ifehanges in the tuents and/or amounts or ratios of the same. in the
media could provide different algal growth teristiea. in on? experiments were
conducted to determine if Scale—up of an algal culture system would alter algal growth
characteristics. in particular. the amounts and ratios of; {54304, Urea, CaClg, MgClg, and
KHZPO4 were modified in an attempt to increase the level of lipid produced by cultured
algae:
Results of tiermentations produced in a hatch volume of 10L are shown below:
332E________________________________________________________________________________________________________________________________________________________________________________________________________________
éliiéfiiifiéélllllllllllllllllllllllllllllllllllllllllllllllllllllllllliiiii?”””””””””iiat:””””””””””””””””””””””””link;””””””””””
*3 ..lflll‘l:ll§9§l§.............ll.§§:ll3f§%ll..,,.,,,,,, ..9§2§ll;....... ..ll§?:§l§:.....................................Q3&3???............
(sf Ll
Sugar
Yeast Extract
2012/046696
Urea 2 2 2 2 1 1
0.1538. E 0.1538
MgCiZ 0.1538 :3 1538 n1538 0.1533 0.5 1
FHFFFF -_ ' i '
Traceé{liguhfi—
Fr' CFFFFFF --—"
_Zn suteifa
--—”
Coppe suwate —-'“
strong NH3 strong NHB i
ESE???............................sme” .3933]?............................................................................................................................................
ph ISSL s ph Issue; '
foam out foam out
TabieZ:10L fermcniatifin condltigns and rewsuits
ingredientsiing N83"
NBSvflBZSii EN83~0&G?11 Nfié—Gfifl?1l NBfi~BfiG711 {E41911 NWMMlSli NBfiOfil‘f-fll
KHZPOA-
Trace d) -
Ferric Chim‘ide
Zn sulfate
j‘fln suifate
Copper 5L:-ifate
Feed :
Ureazi<H2P04 2:0.5 2:0.5 220.5 2:013
PCT/U82012/046696
temp set point
Table 3: ‘delilOllal 10L fermentation eontlit ms and res i.
ingredients/lag 2} {3406141 P48606141 i NBSGSZii NBAQBZ‘li N B603211
iNB§Ofii411 i1 NBSSEZSli NBAOBZBM NBBCSZBM i
(gt) ; -n-h :
________
N 30
U rea
ZrtSO4 C. 15 38
:15-12............... .........t{-1538
MgCi 2 3.15 38
I<H2Po4 2
Trace (liquid) -
mi 10 '
t...................._ .......................
Ferric Chloride
Zn sttifate
Mn suifate
“flatness._____
Copper sulfate
Feed
UreaziiHZ'C-i
temp set point .
i E
fat "/0 46.5? 65.04 67.51 E 61.28 5?.9‘3 58.53 49.25 :34.41 54.97 i
T .
Fomuiar confirmation Natl effects Sait ratio effects .
Tabie 4: onal iOiJ fermentation conditions and t‘esuitst
:3 These experiments, ted during development of embodiments of the invention,
indicated that n amounts/ratios of substrates present within the media had a direct
impact on algal growth teristics (egn, totai biomass achieved as weii as amount off-at
and/or other component content Within the biomass its-sit) Parameters that provided a high
fat content him-tags in the ML runs were then utilized to determine ifthey would he
successfoi for iargc scale production of a high fat content biomass.
EXAMPLE 2
Large scale protiuction of high fat alga} s
ihe ini-iai ts to generate a heterotrophic aigai biomass bed in Example 1
above. utiiized procedures based on yeast fermentation processes. The processes were run in
PCT/U82012/046696
batch due to limitations in the production facility (Nicln‘dasville, KY) and temperatures that
could only be lled between 25 and 38 C. The temperature range was large clue to lacl;
ofprecise control cftlte system, As ted in Table l, above, the fat levels achieved at the
Nicholasville, KY plant ranged from 853%. However, as indicated above, additional
Ui experiments ‘l Vere carried out during development bodimenls of the invention that
provided the identification of certain ratios/amounts of substrates that could be utilized during
heterotrophic algal biomass production to alter algal growth and biomass
generatierr/properties. Modification of the levels and ratios ot‘the media ("cg M53804, Urea,
Calf/lg,” MgClz,‘ and Kl-lgi’04) during fermentation was identified and characterized to alter
l0 algal growth and to generate a biomass with significantly different properties (cg, a
significantly higher fat content biomass). As described below, the process (including media
containing the identified ratios/amounts of substrates ett‘ective in generating a high a:
t algal biomass (eg greater than 67% fat conterrt)) was harther tested and run in large
scale and also as a tch (thereby allowing for modification and l of antounts of
l5 nitrogen, orus. potassium, and carbon during the mm).
A culture ofSeltizocitytritmt [imacinwn was obtained and stored in 1.5inL cryovials at
—80 C. For each culture, a crycvial was thawed and aseptically added to ltlL shalce llaslr of
media. Media in the l L flasks contained the components as shown in Table 5:
ingredient Batched Manufacturer
, . l—Hantmond, lN, USA
Yeast Extract '
. n' lndiananolls, 1N, USA
.' Sigma-Aldrich St. Louis, MO USA
Table 5. Media used for toll. culture.
The temperature of the shake flasks containing Schizochytrz’wn it'macr‘rrtmt in media
was kept at 30 C and shaken at .250 RPM until such time that the algae had entered
logarithntic/exponential growth phase hut prior to ion of glucose in the media {usually
72— M4 hours).
The contents of lL e flasks were then aseptically transferred into 2.0L aspirator
bottles with sterile connectors that were used to connect to larger vessels (40L or ".27 l. or l8
L vessels). Thus the lL culture flask cultures were used as inoculum and aseptically added
to a seed vessel (either 40L or 27L or 18L) containing media described in Table 6 below:
PCT/U82012/046696
Manufaemrer
Cargill — Hammond IN. USA,
Sensiem ~ liidianapnlls, lN, USA
Norkmn limited Kutahya, Turkey
Occidental al Company — Dallas, TX
Norm American SalE y Overland Park,
Table 6 sed for E811 or 27L, first seed cultures.
The firsE seed stage /27L) was run at '36.} C, under airflow and agitation
L11 conditions so as En mainlain dissolved oxygen aE 01‘ above 10%, and uiiEil at least 20 g/L {if
glucose was consumed. When grown under sterile conditions, no pH COITE‘El‘Ol was required.
Kathe} the pH slayeLl Within a healthy lanye> throughout the fermentation ss. Elie first
seed stage (40/ lx’l 7L) was consideiecl completed wlien Ell'gal gromli W218 within
log,exponential giomh stage glucese had 110E been depleteLl from the EnL.die. but at leasE2
l0 gal Ol glucose had-been Ltor‘isumed (inaeneial this oeLLined bemeen about 24-48 hows). A
laiger vessel E400El/2000L} was made readv fer the firs{seed stage culture (e.g., it was filled
with media and bmugln EL) 30 C undel stLrile enndltio113‘:
Upon completion. Liftlie first seed culture The contents oflhe first seeLl stage
(40f! 8/2VllL:uli‘ure vessel was transferred to a vessel with at least 25000}; media described in
Table 7 below:
_‘ 3
Cargill — Hammond, EN, USA
Sensient Indianapolis, 1N, USA
MgSOAl Noi‘lLeni Limited l<LLiEaliya~ Turkey
ental Chemical Company — , EX
North American Salt Company Overland Park:
MgClZ KS
Eablc7Media used foil4 0.00/2000-le seeond seed cul Euros.
PCT/U82012/046696
This second seed stage (4(300/2000L} e was run at 30 C, under airflow and
agitation conditions so as to maintain dissented oxygeia at er above 10%, and until at ieast 2C!
gI’L {If e was consumed. When grown under sterile conditions, no pH comm} was
required. Rather, the pH stayed within at healthy range ihi‘eughout the tatien process.
U1 The second seed stage (4000/20001.) was considered emepleted when algal growth was
within log/experiential growth stage: glucose had not, been depleted free: the media, but at,
least 20 gl of glucose had been consumed (in general. this eeeurred between about 24—48
hours).
Upon completion ufthe sewed seed (40(llil/ZGQOL) culture! the cements of the seee-nd
I0 seed e weie caliy transferred into a third culture vessel with a volume ranging
between 70,090 L, :0 220,000 L of sterile media at 30. C as described in Table 8 below:
Batehed Manufacturer
50 g/L Czargill Hammond, IN USA
I5 vessei (70,000220fi99 L vessel), glucose and fedbateh feeds were started Glucose was
ined at ill g/L {luring large scale culture ofalgae in the third culture vessel (70,000"
ZZUAEQD l. vessel). As described in Table 9 belew, the feed used for the fed~b3tel1preeess
eentained:
Table 9, Feed used fer fed~beteli process,
PCT/U82012/046696
The fed batch feed was added over a. 34 hour period. Although an understanding ol‘
the mechanism is not needed to practice the presem‘ haveu’lieu, and while the present
ihvehlhm is not limlled to any parlicular mechanism 0? aeliuh, in sum > cllmehte, this
Ui time period was fied based upon the valiun lhal ll leek ~ 20 hours fur the feed to
Start (fur 30 g,” of glucose to he consumerl by {he algae present in the third culture vessel).
The feed was their stepped (e. go. at aruuml lug huur 54) in urder m allow all of the nutrients m
be remeved (cerisumecl) frum the media. Harvesl of the algal hlemass took place upuh the
leririiiiatiuri ol‘expuuemial growth, occurring generally between the lug hours 66-76.
l0 'l'he culture hrmlr was ale—“sludge centrifuged under (renditions to e 15—30%
solids, with the concentrate spray dried to remove water to a final moisture of less than 5%.
s of several independent, large scale cultures are shown in Figure l and Tables
ML- 12 below:
Run Fat % Vol 0/6 recovery Far 9/0 Protein 9/6; lVlOlSlll‘IQ %
number st adjusted {rem ll (spray dried (spray spray dried
sample) Biomass centrifuge 'l product) dried. product
Table l0. Large scale production culture results,
l’had harvest sample
preeess control problems will: this batch
o E l ~2—ll
*1 Had a batch v olume 0f7l'l,llll(l L and a harvest volume of
93,700 L
a li'l~3—ll
I! Had a batch ‘v‘ulume of 70,000 L, and a harvest velume 0?
84,000 L,
o Fl—A’M l
I! Had a batch volume of 70,000 L and a harvest volume of
92,300 L
0 E l--ll
Had a batch volume $70,000 L and a harvest volume of
(A! r
v 82,300 L
0 Fl -6—l l
I“ Had a batch volume uf 80,090 I. and. a harvest volume of
83,600 E.
o FZ-le-ll
PCT/U82012/046696
.. Had a batch volume of 1 10,000 L and a harvest volume of
113,000L
o FZ—Z-H
'4 Had a batch velume 0f 1 “£000 L and a harvest vehrme of
U1 IESVGOOL
The biemass generated from each large scaie, fed-batch culture was characterized;
including unaiysis 0f the total fat (saturated and rated fat) t; moisture,
doeesehexaenoic acid (DI-iA'menten’r, palmitie acid cmrterrt, crude protein content and ash
cement (See; eg Fer cement end/Tviuisrtrre AOCS Am 5-04 ‘Rnpid Determinatien of
Oil/Fat Utilizing Big1} Temperature Solvent Extraction” V: 3/31/10; Palmitie — AOCSS
Mefimd Ce 113-89 and AOAC Method ef Anaiysis 9'9} 3'9; Protein — AOAC 990.03; Ash -
AOAC 942.05 V01 adjusted Biomass (gr/L) Stene, er. a}. Dry Weight Measurement of
Micrebiai Biomass and Measurement Variablrty Analysis. Bioreehneiogy Techniques. VGE
6: 207- 211.2
”Neil
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
' i T i
E E Crude i r
= FAT ’60 E a A
: TQTAF
re DHA i Paimitic Preterm {‘56) ‘5 E i 1.
Run #fCemments (Fmai g ; max g
(9;) Max {0/‘3 t J”) (mglg1.} (m'/g g ) Re 0W0“”p
t) E "
% i
: i reiease
H11117201391918379143639
______
germ-11 é ~ - .
sens—11 15.92 s 11
SL—Fl—S—ll
SL--F2-Z-11 247.2
197.36
SL—FZ-d—llw
gr—rz—g-ri
sews-11
SL-—F2-~11-11
grams—r1 202.51: 250.01 10.02 3.4g
sen—134‘ 70.95 1.56; 326.94 12.39 4.59
sen-1441
PCT/U82012/046696
SL—F1-1E3-11
SL-Fl-lS-l
SisF 1 — 16— 11
SL~F3—8—11
SL-Fl-—25-—ll
S§.--F3-11
5L~F311
SL~F1~1>12
Crude
TOTAL FAT 96 . :
Moisture. Protein {‘56}
Run #[Ccammems E
{Final
(‘36) Max 6% Report on
Harvest)
e E
ESL—1514142 159.54
SL-FIi—S‘ZEZ 171.73
. 5- .4.
ELM—3&2
176.68 u. m 6'- Eu.) m ,..x O m {7‘ ,..E
172.91
SL- 2
Si.~F3—9~1 2 E 69.18 1.74
Tabie 12. Characterizatinn of large scale cultures
2012/046696
Additionally, the fatty acid profile oftiie biomass was characterized. As shown in
Figure 2, the fatty acid profile ofeaeh algal biomass generated is highly similat/consistent,
independent of the total fat content of the s. A eonigmsite fatty acid profile, taking into
Ui consideratien the collective profiles ol’all samples analyzed, is provided in Figure 3.
The glyceride profile was also determined for each algal biomass” Oftlie total
glyceritle eohteht e-‘f the big-mass? about 4~8% were diglyceritles. less than 1% glycerol, about
3-7043 ycerides and about 84~88% triglycerides.
EXAEWFLE 3
Biomass harvesting
Experiments certducted during development of embodiments oi‘the invention
identified that the increased total fat levels in the biomass caused significant problems with
regard it} eeii‘trilugatioh ofthe algal biomass. Recevery of liemass content nest~
fugatieii ranged from only about 45-85% total biomass weight. This is shown, fer
example, in Table 13 helew:
........................................"""""""'"""',“" ......
; Run Fat 0/5 Vol Protein % Fat "m Protein e,
l number (harvest adjusted (harvest iron} itspraydriod (spray spreydricd
sample) Biomass sample) centrifuge product) dried product
Product‘s
t,
*ljacl harvest sample” process control problems with this hatch
E l .,3__1 l
N Had a hatch volume $70,000 L and a t velome of
93,700 L
la.) Li! F l ~3—ll
E Had a hatch volume of 70,000 L and a harvest vohime of
849000 L
El 4—11
I“ Had a batch volume $70,001:) L and a harvest volume of
U.) :3; 92,390 L
1315—11
1/: {N}
2012/046696
.. Had a hatch volume of '?O,{.){30 L. and a harvest voinme of
82,300 L
F 1—6—1 1
'4 Had a hatch veiume of'hflflflh L and a harvest voiume of
83.600 L
EZ--i--1 1
I Had a batch volume of i 10,990 L and a harvest volume of
113,()(}()L
E'Z-Z—i i
I“ Ha i a bateh voiume hi i 10,089 L and. a harvest volume of
1935,6001,
The reeoveiy problems were fied to be attributable to the increase in the amount
of low density lipid/nil in the biomass. Thus, experiments were centiueted during;
embodiments of the invention in an effort to address this prehiem.
One approach that tiispiayed the abiiity to enhance recovery of the biomass was to
ehih the euiture eoniprising the aigai biomass prior to e n rifngatien. Aithough an
understanding ei’a nieehanism is not needed to practice the ion and the invention is
not iirnited to any particular mechanism of action, in some embodiments, ehiiiing the enitnre
increased the density of the iipizi/oii and aiiowed a iarger recovery of the biomass
Experiments were conducted in order to determine the effects of ehiiiing the biomass
before centrifiigation.
Lab triai one: ‘2 gaiinns ofhroth eoiieeted and stored at 7—8 C. for 16 pins hours“
Eight X 50 mi centrifuge tubes were eoiieeteti and pine-ed in a water hath to reach target
[\J Li] atures described in table E4 heinw. Aii s were centrifuged at 5000 rpm for 5
minutes.
Temperature iC} Visual Observation
ent separation with no floating eeiis.
Ciear supernatant
_2_O________"5351i"""séfiéiéiihii"""{t7iiiifiiiimii‘é‘aiiii;wee-ii:
Cioudier than 10C
ar to 20 C; eionriier
Good. separation with no floating
Good separation with ne floating eeiis; very
e i on riy
1/: wJ
PCT/U82012/046696
510 Still separating; floating cells; milky
supernatant
Poor separation
Almost no se iteration with numerous tloatin-‘té:
Lab trial 2:: Fresh broth samples were collected and tested over a ature range of
lO—Sth. They were not refrigerated overnight as in trial 1, All samples were allowed to sit in
an ice water bath to target ature. Samples were fuged at 5009 1pm for 5 minutes.
Temperature Visual Observation Density (fig/[111D
EExcellent separation with no floating
cells, Clear atant.
E Good separation with no floating cells.
2 Very cloudy supernatant
ESample still separating; Visible
; flocculation
E‘v’eiy similar to 20C; increasing
cloudiness
EStill Good Separation; increasing
cloudiness
Table l3" Cultiire tempo "attire and centrifugation results of trail 2.
ll} As described in Example '2 and Figure l, during large scale production chilling oi‘the
biomass prior to ry (centrifugation) lend to significant increase in total recovery of the
biomass" Multiple large scale rims have been completed with total ry of approximately
95%.
All publications and patents mentioned in the above specification are herein
lS incorporated by reference Various modifications and variations ol‘the described
compositions and methods oftne invention will be apparent to those skilled in the art Without
PCT/U52012/046696
departing {Tom the scope. and spirit ofthe invemion. Aitizougi‘i ihe invention hat: been
described in connection with specific preferred embodiments, ii shouid be understand that the
invention as claimed shonid 1103‘, be nnduiy d to such specific embodimenfi indeedg
various modifications of the described modes for carrying out the ion that are Obi/inns
U] to these skilled in the relevant fields are iniended to be within Ehe scope of ihe present
inv eniinn.
Claims (24)
1. A s of making an algal biomass comprising at least 67% total fat comprising culturing an algae in two or more types of culture medium sequentially, culturing the algae in a culture medium sing a carbon source, yeast extract, a magnesium source, and a calcium source; and subsequently, culturing the algae in a culture medium comprising a carbon source, a yeast extract, a nitrogen source, a phosphate source, a magnesium source, a calcium , and 4 g/L or less of sodium chloride, n the nitrogen and phosphate are in a ratio of 50:1 to 4:1.
2. The process of claim 1, wherein one culture medium of the two or more e medium contains 50 g/L of a carbon source, 7.5 g/L yeast extract, 0.15 g/L magnesium sulfate, 0.15 g/L calcium de and 0.15 g/L magnesium de.
3. The process of claim 2, wherein the carbon source is a sugar.
4. The process of claim 3, wherein the sugar is glucose.
5. The process of claim 1, wherein one e medium of the two or more culture medium contains 50 g/L of a carbon source, 7.5 g/L yeast extract, 4.0 g/L magnesium sulfate, 1 g/L urea, 2 g/L calcium chloride, 2 g/L magnesium chloride and 0.25 g/L monopotassium phosphate.
6. The process of claim 5, wherein the carbon source is a sugar.
7. The process of claim 6, wherein the sugar is glucose.
8. The process of claim 1, wherein one culture medium of the two or more culture medium contains a carbon source, yeast extract and sea salt.
9. The process of claim 8, wherein the carbon source is a sugar.
10. The process of claim 9, wherein the sugar is glucose.
11. The process of claim 1, further comprising culturing the algae in a culture medium containing e, yeast extract and sea salt prior to the culturing in the culture medium comprising a carbon source, yeast extract, a magnesium source, and a calcium source.
12. The process of claim 1, wherein the culture medium sing a carbon source, a yeast extract, a nitrogen source, a phosphate , a magnesium source, a m source, and 4 g/L or less of sodium chloride, n the nitrogen and phosphate are in a ratio of 50:1 to 4:1, is supplemented with a fed-batch feed.
13. The process of claim 12, wherein the fed-batch feed comprises urea and tassium phosphate.
14. The s of claim 12, wherein the algal biomass is harvested from the culture medium between 12-24 hours after cessation of the fed-batch process.
15. The process of claim 14, n the algal biomass is harvested from the culture medium after all of the nutrients have been removed/consumed from the medium.
16. The process of claim 14, wherein the algal biomass is harvested via centrifugation of the culture medium comprising the algal biomass.
17. The process of claim 16, wherein the culture medium is chilled prior to harvesting the algal biomass.
18. The process of claim 17, wherein the culture medium is chilled to between about 5 and 25º C.
19. The process of claim 1, wherein the algae is Schizochytrium limacinum.
20. The process of claim 11, wherein the culture medium contains 50 g/L e, about 10 g/L yeast extract and about 4 g/L sea salt.
21. The process of claim 1, wherein the culture conditions comprise running the algae culture at 30º C under airflow and ion conditions so as to maintain dissolved oxygen at 10%.
22. The process of claim 1, wherein algae are cultured under sterile conditions.
23. An algal s prepared according to the process of claim 1.
24. The process of claim 1, wherein the culture medium comprising a carbon source, a yeast extract, a nitrogen source, a phosphate source, a magnesium source, a m source, and 4 g/L or less of sodium chloride, wherein nitrogen and phosphate are in a ratio of 50:1 to 4:1, has magnesium and calcium in a ratio of 4.5:1 to 1:1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161507390P | 2011-07-13 | 2011-07-13 | |
US61/507,390 | 2011-07-13 | ||
PCT/US2012/046696 WO2013010090A2 (en) | 2011-07-13 | 2012-07-13 | Algal lipid compositions and methods of preparing and utilizing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ618123A NZ618123A (en) | 2015-01-30 |
NZ618123B2 true NZ618123B2 (en) | 2015-05-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2837215C (en) | Algal lipid compositions and methods of preparing and utilizing the same | |
Hamed | The evolution and versatility of microalgal biotechnology: A review | |
Spolaore et al. | Commercial applications of microalgae | |
ES2116288T5 (en) | Docosahexanoic acid, processes for its production and compounds containing it | |
CN102884201B (en) | Produce microorganism, lipid acid constituent and preparation method thereof and the purposes of timnodonic acid | |
Colla et al. | Antioxidant properties of Spirulina (Arthospira) platensis cultivated under different temperatures and nitrogen regimes | |
JP6807329B2 (en) | Methods and applications for culturing ω-7 fatty acid compounds and yellow-green algae to produce the compounds | |
WO1996033263A1 (en) | Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms | |
KR102202287B1 (en) | Biomass of the microalgae schizochytrium mangrovei and method for preparing same | |
CN103930104A (en) | Fatty acid compositions | |
CN102597255A (en) | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae | |
Ghasemi et al. | Algae for the production of SCP | |
CN105452442A (en) | Methods of producing algal cell cultures and biomass, lipid compounds and compositions, and related products | |
Sastre | Products from microalgae: an overview | |
NZ618123B2 (en) | Algal lipid compositions and methods of preparing and utilizing the same | |
JP2621100B2 (en) | Mutant strain YZH of Pseudomonas and method for producing 851 YZH nutrient solution by applying this strain | |
Dvir et al. | A Foodomics Approach Reveals Hypocholesterolemic Activity of Red Microalgae | |
GB2233666A (en) | Microbacterium 851R, and a process for producing 851 nutrient solution | |
JP7097014B2 (en) | Algae and their use | |
AHMED | PRODUCTION TECHNOLOGY AND CHEMICAL COMPOSITION OF SPIRULINA (Spirulina platensis) IN BANGLADESH | |
OA16793A (en) | Algal lipid compositions and methods of preparing and utilizing the same. | |
Setyawan et al. | The hidden superfood: Microalgae from Indonesia and its potency as functional food ingredients | |
Khodadadianzaghmari et al. | Biochemical profile of Scenedesmus isolates, with a main focus on the fatty acid profile | |
JP2023110898A (en) | Thrombosis preventive agent | |
JP2019092480A (en) | Algae, nutritional agent, composition for supplementing nutritional component and method for producing nutritional component |